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ABSTRACT 
Aflatoxin B1 (AFB1) is one of the most toxic substances known to man and chronic 
exposure to low doses has been implicated in hepatic cancer.   Strict regulations have been 
imposed world-wide to significantly reduce food and animal feed contaminated with AFB1 
from entering the food stream.    
The purpose of this study was to develop an antibody-based diagnostic kit for aflatoxin B1 
using surface plasmon resonance (SPR).  SPR is an innovative optical technique that 
measures biomolecular interactions on the surface of a sensor chip.  Advantages of SPR are 
that it is label-free, high-throughput, it does not use large volumes of solvents and is both 
accurate and sensitive. 
A wide range of crops are susceptible to AFB1 contamination.  Several of the most 
commonly affected were chosen for investigation. .  The first studied was compound feed 
which was purchased from IRMM as certified reference material for aflatoxin analysis.  
This was chosen to investigate first as the compound feed was produced from naturally 
incurred aflatoxin contamination and was not a spiked sample.  It therefore closely 
resembles a real sample. Preliminary studies showed recoveries of 98%. 
The second matrix chosen was infant formula.  When this study had started there were 
currently no high throughput assays commercially available that were sensitive enough to 
detect aflatoxin to the legislative levels.  The purpose of this study was to eventually create 
and market an aflatoxin B1 testing kit.  If we could develop a kit that would detect aflatoxin 
B1 to these levels it would be a unique selling point of our kit.  Unfortunately, due to matrix 
interference problems we were not able to achieve an assay sensitive enough to detect to 
the legislative limits. 
 
The third and fourth sample matrices chosen were maize and peanuts.  The preliminary 
studies showed that recoveries of 111% and 86 – 103%, respectively, were possible.
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Introduction 
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1.1 Mycotoxins 
 
Mycotoxins are toxic secondary metabolites produced from a range of toxigenic 
filamentous fungi (moulds), predominantly from the genera Aspergillis, Penicillium and 
Fusarium (Sweeney et al., 1998).   Some originate from a particular species, for example, 
only A. flavus or A. parasiticus produce aflatoxins, whilst patulin is produced by a variety 
of different moulds from the species Penicillium, Aspergillus and Byssochlamys (Alves et 
al., 2000).  Some other moulds can produce several mycotoxins.   Fusarium species can 
produce tricothecenes, fumonisins, zearolenone (ZEA), deoxynivalenol (DON) and 
monoliform amongst others (Creppy, 2002).  However, the maximum production of 
different mycotoxins may not occur under the same conditions.  A single strain of 
Fusarium graminearum can produce both ZEA and DON.  However, while ZEA 
production reaches a maximum at 25ºC, DON production increases with increased 
temperature, the maximal amount being produced at 30 ºC (Ramirez et al., 2006) 
 
Certain environmental conditions favour mycotoxin production.  These conditions are more 
restricted than those needed for normal fungal growth (Kokkonen et al., 2005).  Production 
of particular mycotoxins is also dependant on the climate.  Some mycotoxins, such as 
ochratoxin A produced by P. verrucosum, favour temperate climates and are, therefore, 
found predominantly in Europe.   Others, for example aflatoxins, occur more commonly in 
tropical climes. They are produced when the crop is under stressed conditions and this is 
accelerated by crop damage e.g. by insect infestation (Pier, 1992). 
 
Since mycotoxins can occur all over the world, all crops are susceptible to contamination, 
and this can happen at any stage of the farming process, including cultivation, harvest, 
drying, storage, or transportation. Major commodities affected are cereals (maize, wheat, 
barley, oats and rice), nuts, dried fruit, coffee, cocoa, spices, beer and wine. Mycotoxins 
can also enter the human food chain through the meat of livestock that have eaten 
contaminated feed, or from their milk, cheese or eggs (Bintvihok et al.,  2002; Battacone et 
al., 2003; Van Eikeren et al., 2006).   Many mycotoxins are stable to heat and other effects 
of food processing.  Therefore, processed foods, especially those intended for children, 
have to be tested for contamination.  
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 The functions of mycotoxins are not fully understood.  Mycotoxins are secondary 
metabolites, and as such they are not involved in fungal growth, respiration or reproduction.  
A range of theories have been put forward as to their precise physiological roles.  
Suggestions include that they may be waste products, that they have antibiotic properties, 
that they were developed as a chemical defence system or they may facilitate 
communication between moulds (Etzel, 2006; Ciegler, 2007). 
 
Approximately 400 mycotoxins exist.  Only six or seven, however, are considered 
significant, as they are causative agents for a large range of food-borne illnesses in both 
humans and livestock.  These mycotoxins are the aflatoxins B1, B2, G1 and G2, ochratoxin 
A, fumonisin, deoxynivalenol, zearalenone, tricothecenes and patulin.  
   
The detrimental effect of fungal toxins was first uncovered in the 1960‟s when the 
consumption of contaminated peanut meal from Brazil lead to the death of 100,000 turkeys 
in England.  Subsequently, it was discovered that the meal had been infected with the 
mycotoxin aflatoxin B1 (Diaz, 2005).    
 
Since then, mycotoxin contamination was linked to many and varied human disorders 
depending on the type and dose of the toxin.  Acute cases of mycotoxicosis, where large 
amounts have been consumed, are generally confined to the developing countries.  An 
example of this is the acute aflatoxicosis outbreak in Kenya in 2004, which resulted in 125 
deaths due to the consumption of contaminated maize (Niyikal et al., 2004; Aziz-
Baumgartner et al., 2005; Lewis et al., 2005).   Chronic cases of mycotoxin contamination, 
where small amounts of the mycotoxin have been ingested over long periods of time, have 
been associated with a wide variety of diseases targeting several organs in humans and 
animals.  These include Balkan Nephropathy (ochratoxin A) (Petkova-Bocharova et al., 
1991), Reye‟s Syndrome (aflatoxins) (Trauner al.,  1984), alimentary toxic aleukia 
(tricothecenes) (Lutsky et al., 1983) and oesophageal cancer (fumonisins) (Chu et al., 
1994). 
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Most of the epidemiological research has focused on the individual effects of mycotoxins.  
However, several mycotoxins are able to contaminate the same commodity concurrently 
(Fernandez al., 2001; Domijan et al., 2005).  For example, corn can be infected with 
fumonisin, aflatoxin, zearalenone and/or ochratoxin, and there is a positive association 
between the presence aflatoxin and patulin in Turkish dried figs (Karaca et al., 2006).  
Therefore, recent studies have investigated the simultaneous effects of mycotoxins, or 
whether they act additively, synergistically or antagonistically.  
 
An additive effect is when the cumulative effects of two mycotoxins are equal to the sum of 
the separate effects.  However, a synergistic effect is when the interaction between the 
mycotoxins causes a greater effect than just the sum of the individual mycotoxin‟s effect, 
whereas an antagonistic effect lessens the combined effect of the mycotoxins through the 
interference of one mycotoxin with the effect of the other. 
 
Aflatoxin has an additive affect on both DON and fumonisin B.  It acts synergistically with 
T2 toxin and ochratoxin A, but works antagnostically with monoliform.  A study (Huff et 
al., 1986) showed the synergism between AFB1 and T2 by feeding broiler chickens a diet 
containing either: 
- 2.5μg/g aflatoxin B1 
- 4.0 μg/g T-2 
- 2.5μg/g aflatoxin B1 + 4.0 μg/g T-2, 
and comparing it to uncontaminated feed. 
By the end of three weeks, the results show that with the combined diet there was a weight 
drop of 28% when compared to the control, whereas with AFB1 and T-2 alone there was a 
12% and 8% drop, respectively.  A synergistic effect was also noted with respect to the 
increase in relative weights of the kidney, liver and spleen, and also with the reduction of 
serum protein, glucose, albumin and potassium levels.  In a similar experiment, Huff et al. 
(1984) also showed the synergistic effect between aflatoxin and ochratoxin A.  Boiler 
chickens given feed containing either AFB1 (2.5μg/g) or ochratoxin A (2.0μg/g) or both 
combined, showed that the diet containing both toxins caused a drop in body weight of 39% 
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compared to aflatoxin (12%) or ochratoxin A (14%) alone.  The reason for this may be that 
when these toxins are combined they are more effective at disrupting protein synthesis. 
 
The FAO estimates that 25% of the world‟s crops are contaminated with mycotoxins.  It is, 
however, difficult to calculate the total economic losses as, in addition to losses of crops, 
mycotoxin exposure to livestock can cause loss due to reduced fertility, stunted growth and 
impaired immunity. 
 
1.2  Aflatoxins 
 
Aflatoxins are produced from particular strains of the species Aspergillus flavus and 
Aspergillus parasciticus and only under certain environmental conditions.  Aspergillus 
grows favourably under hot and humid tropical or sub-tropical conditions.  Temperature 
range for growth is between 28 and 33ºC and at the water activity of about 0.83-0.97aw, and 
are predominantly found in acidic soils and decaying vegetation (Ehrlich et al., 2005).  The 
climate in Europe does not lend itself to aflatoxin production, and so the risk for 
contamination is low.  Nevertheless, occurrences have been reported for stored maize in 
Northern Italy.  Aflatoxins can contaminate a wide variety of commodities, for example, 
cereals (maize, wheat, rice, sorghum, millet), nuts (pistachios, brazil nuts, peanuts, walnuts, 
coconuts), spices (chilli, tumeric, paprika, black pepper, ginger), dried fruit, seeds and milk. 
 
There are 17 related aflatoxin metabolites (McClean and Dutton, 1995).  Only four of these 
are the main contaminants found in food.  These are aflatoxins B1, B2, G1 and G2, named 
after their natural fluorescence under UV light - B1 and B2 have a blue fluorescence, whilst 
G1 and G2 are green.  B1 is the most predominant aflatoxin, usually present in greater 
concentrations than the sum of the other three, and it also has the greatest toxicity.   Two 
toxic hydroxy metabolites, M1 and M2, are formed and excreted via the milk and urine of 
the mammal that has consumed contaminated food.  This is especially significant for dairy 
cows, as their milk will contain these toxins if they have eaten feed containing aflatoxins.  
0.3 – 6.2 % (w/v) of the AFB1 in animal feed is transformed into M1.  M1 can also be 
passed in human breast milk to nursing babies. 
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Figure 1.1 Chemical structure of aflatoxin B1, B2, G1 and G2. 
 
 
1.3  Physical and chemical properties 
 
Aflatoxins belong in a family of chemical compounds called coumarins.  They are 
crystalline solids that are soluble in polar solvents such as methanol, acetonitrile, acetone, 
chloroform, dichloroethane, ethyl acetate and dimethyl sulfoxide.  They dissolve in water at 
a concentration of 10–20mg/L.  The molecular weights of aflatoxins differ slightly.  B1 is 
312, B2 314, G1 328 and G2 is 330, and their melting points are 268°C, 286°C, 289°C and 
237°C, respectively.  They are very stable in the absence of light, even at temperatures 
above 100ºC when in a dry state.  In the presence of moisture, however, long periods of 
elevated temperatures can cause the lactone ring to open, making them susceptible to 
decarboxylation.   
 
Aflatoxins can be deactivated by alkali due to the hydrolysis of the lactone ring.  Therefore, 
addition of ammonia or hypochlorite is often used in labs to decontaminate aflatoxins.  
Aflatoxin B1 
Aflatoxin G2 Aflatoxin G1 
Aflatoxin B2 
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However, if the basic conditions are mild, acidification can reverse the reaction forming the 
original aflatoxin. 
 
1.4  Epidemiology 
 
Aflatoxins, especially B1, are the most potent naturally occurring toxins, primarily targeting 
the liver.  Exposure to large doses of aflatoxin B1 can cause acute toxicity in both animals 
and humans, whereas chronic toxicity caused by prolonged exposure to lower doses is 
carcinogenic.  It was described by the International Agency on Research on Cancer (IARC) 
in 1993 as a group I carcinogen. This means that there is sufficient evidence available to 
implicate aflatoxin as causative of human hepatocellular carcinoma (HCC).  They are also 
teratogenic, mutagenic and immunosuppressive (Kihara et al., 2000). 
 
Acute toxicity has been studied in a wide range of animals from trout to primates (Pier et 
al., 1992).  The susceptibility of a species to aflatoxin exposure varies (Table 1.1). In most 
animal studies, however, exposure resulted in hepatocellular and/or cholangiocellular liver 
tumours, including carcinomas.  The LD50 scores, the dose required to kill half the 
population, are generally between 0.5 and 10mg/kg body weight.  Susceptibility to 
aflatoxicosis has also been shown to be gender-specific in both rat and mice studies, with 
males being more sensitive than females. 
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Table 1.1 Acute toxicity of aflatoxin B1 expressed as a single oral dose LD50 (Cardona et 
al., 2000) 
Species LD50 mg/kg bodyweight 
Rabbit 0.30 
Duckling (11 day old) 0.43 
Cat 0 55 
Pig 0.60 
Rainbow trout 0.80 
Dog 0.50 - 1.00 
Sheep 1.00 - 2.00 
Guinea pig 1.40 - 2.00 
Baboon 2.00 
Chicken 6.30 
Rat (male) 5.50 - 7.20 
Rat (female) 17.90 
Macaque (female) 7.80 
Mouse 9.00 
Hamster 10.20 
 
 
 
Adult mice are resistant to aflatoxin-induced liver cancer.  However, infant mice are 
extremely susceptible – aflatoxin causes cancer in 4-day old mice, but mice that are a week 
old are resistant.  Studies in changes of gene expression in mice by Essignmann (1982) may 
help to explain why some species, or genders, are more susceptible than others. 
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Exposure to fatal doses of aflatoxins (>6000mg) are rare, with outbreaks confined to the 
developing countries, and are caused by contamination of a staple food, such as rice, maize 
or wheat.  The most recent outbreak of aflatoxicosis was in Kenya from January to June 
2004, where maize stocks had been contaminated to concentrations as high as 4,400 ppb, 
over 220 times greater than the regulatory limits set for Kenya (Niyikal et al., 2004; Aziz-
Baumgartner et al., 2005; Lewis et al., 2005). This episode resulted in 317 cases and 125 
deaths Since then several isolated instances of aflatoxin fatalities have occurred. For 
example, 5 deaths were reported in April 2006 in the Makueni district of Kenya.  In total in 
Kenya alone over the last 2 years 100 known fatalities caused by aflatoxins were reported 
(FAO/WHO). 
 
Aside from cases of acute aflatoxicosis, chronic doses of aflatoxin over extended periods of 
time can also be attributed to many deaths in the developing world.   
 
Aflatoxin has a positive association with hepatocellular carcinoma, which is the fifth most 
common and the third most fatal cancer worldwide, causing an estimated 500,000 deaths 
annually.  Other deaths that have been linked to aflatoxin contamination are caused by 
either the loss of immunity or malnutrition, especially to the old and very young.  Aflatoxin 
in weaning foods or breast milk from a mother who has consumed contaminated food can 
cause stunted growth and underweight children. Also, reduction  in immunity caused by 
aflatoxin consumption can lead to increased susceptibility to a range of diseases, for 
example AIDS, or infections from drinking unsafe water. 
 
Fatalities from acute aflatoxicosis are not restricted to humans, a recent example was in 
January 2006, where over 100 dogs died due to the contamination of dog food in America 
(Leung et al., 2006; Stenske et al., 2006).  Symptoms included loss of appetite, jaundice, 
severe vomiting combined with bloody diarrhoea and a fever.  All dogs died of liver failure. 
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1.5  Mechanism of AFB1-induced DNA damage 
 
After ingestion, aflatoxin is transported to the liver, where it is oxidised by the enzyme 
cytochrome P450 (McClean and Dutton, 1995; Turner et al., 1998).  The function of 
cytochrome P450 is to convert toxins into a more soluble form to facilitate their removal 
from the body via the kidney.  However, in the case of aflatoxins, the enzyme forms an 
intermediate through the addition of an oxygen onto the aflatoxin molecule, converting it to 
a highly reactive and mutagenic compound, AFB1-8,9-epoxide (Figure 1.2).   
 
The epoxide can be deactivated by addition of a glutathione molecule, facilitated through 
the enzyme glutathione S-transferase, making it more water soluble and easier to eliminate 
from the body.   However, due to the reactive nature of the epoxide, there is not enough 
time for this reaction to be completed, and the intermediate can attack DNA. AFB1-8,9-
epoxide can exist as two stereoisomers in an exo and an endo conformation.  AFB1- exo-
epoxide is 1000 fold more reactive than the endo form, and can react with DNA forming 
AFB1 adducts with a yield of 98%, despite having a half-life of only one second in aqueous 
buffer (Bedard et al., 2006).  Mice are able to express constitutively an α-class glutathione-
S-transferase which has higher specificity to AFB1-exo-epoxide, resulting in faster 
detoxification by glutathione conjugation.  This has been linked to the relative resistance 
mice have to the toxicity of aflatoxins (Wang et al., 2000).  
 
The primary DNA adduct that the epoxide forms is 8,9-dihydro-8-(N
7
-guanyl)-9-
hydroxyaflatoxin B1 (AFB1-N7-Gua) when the C8 position of the epoxide reacts with the 
N7 position of guanine in DNA (Bedard et al., 2006).  The formation of AFB1-N7-Gua is 
directly proportional to the amount of AFB1 ingested and, as it is excreted via urine, several 
human studies have exploited this correlation to investigate the relationship between dietary 
exposure to AFB1 and hepatocellular carcinoma (HCC) (Groopman et al., 1992, Groopman 
et al., 1993; Groopman et al., 1996). 
 
AFB1-N7-Gua is unstable due to the positive charge on the imidazole ring, with a half-life 
of 7.5 hours in rat liver (Wang and Groopman, 1999).  It is then broken down to form two 
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secondary compounds.  The first is due to depurination leading to the formation of an 
apurinic (AP) site.  The second, is produced when the mildly alkali conditions hydrolyse 
the imidazole ring, opening it up, resulting in the creation of the stable AFB1-
formamidopyrimidine adduct (AFB1-FAPY) (Bailey et al., 1996; Keller- Seitz et al., 2004).   
 
It is the AFB1-FAPY adduct that has been implicated as the causative species for HCC.  
Both AFB1-N7-Gua and AFB1-FAPY adducts alter the structure of DNA.  However, AFB1-
FAPY is less distortive and thus is more resistant to repair through the nucleotide excision 
repair pathway.  This adduct is, therefore, resistant and can interfere with DNA replication.  
It is probably responsible for the G to T transformation in the third position of codon 249 of 
the p53 tumour suppressor gene that is associated with over 50% of AFB1-related 
hepatocellular carcinoma (Aguilar et al., 1993; Bailey et al., 1996; Smela et al., 2002).  
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Figure 1.2 Diagram showing the Aflatoxin B1 metabolic pathway 
Aflatoxin is enzymatically altered by the liver by cytochrome P450 system producing the compound AFB1-8,9-epoxide.  This 
epoxide can then be deactivated by the addition of glutathione mediated by the enzyme glutathione S-transferase, and is then 
excreted via the urine.  The epoxide, however, is very reactive and can quickly form an adduct with DNA, 8,9-dihydro-8-(N7-
guanyl)-9-hydroxyaflatoxin B1 (AFB1-N7-Gua).  AFB1-N7-Gua can then be excreted via urine, but is extremely unstable.  It can 
quickly break down into two secondary compounds, an apurinic site and a stable AFB1-formamidopyrimidine adduct (AFB1-
FAPY).  AFB1-FAPY has been implicated as the causative species for hepatocellular carcinoma (Smela et al., 2001) 
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1.6  p53 
 
p53 is a transcription factor that plays a role in many anti-cancer mechanisms.  It regulates 
the cell cycle, promotes DNA repair and initiates apoptosis (or programmed cell death).  
P53 consists of 3 domains, a C-terminus from amino acids 280 – 390, which is the domain 
that allows the molecule to self-oligomerise to form tetramers, the middle region, consisting 
of amino acids 80 – 290 that is the DNA binding region, and the remainder, the N-terminal 
region, which is the part that confers transcription activation capabilities (Wang et al.,  
1994). 
 
Aflatoxin causes a mutation in the third position of codon 249, where an arginine is 
converted to a serine.  This amino acid convertion is a „loss-of-function‟ mutation, and 
destroys the ability of the p53 molecule to bind with DNA.  Molecules that have these 
mutations bind to wild type p53 molecules and then prevent them from activating 
transcription.  If there is a mutation in the gene encoding p53, tumour suppression is 
drastically compromised. In fact, a mutation in this gene is implicated in 50% of all human 
cancers (Smela et al.,  2001). 
1.7  Hepatitis B  
 
Studies with transgenic animals have shown that Hepatitis B virus (HBV) infection and 
AFB1 exposure act synergistically in the development of hepatocellular carcinoma (HCC) 
(Kew, 2003).  Another study has shown that a person is three times more likely to develop 
HCC when they test positive for AFB1-N7-Gua and are seven times more likely when they 
are infected with HBV.  However, when a person tests positive for both AFB1-N7-Gua and 
HBV, they are sixty times more likely to develop the disease (Smela et al., 2001). This 
explains why in areas that both HBV and aflatoxin consumption are prevalent, 
predominantly in the developing world, instances of HCC are high.  For example, in 
Mozambique and in some provinces in China 65-75% of males and 30-55% of females of 
all cancer deaths are HCC, compared to 2% in the United States (Sell, 2003).   
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The mechanism for synergism effect between HBV and AFB1 is still not fully understood.  
Several hypotheses have been suggested (Kew, 2003).  These include, the involvement of 
the 17kDa HBV X protein (HBx), which is required for the establishment of the virus.  It is 
thought that this protein inhibits nucleotide excision repair, allowing the persistence of 
DNA-AFB1 adducts and thus allowing an increased frequency of mutations (Smela et al., 
2001).  Another suggestion is that the HBV may induce cytochrome P450 production, 
which would increase the amount of AFB1 conversion into the more reactive AFB1-8,9-
epoxide (Kew, 2003).  
1.8  Other diseases associated with AFB1 
 
AFB1 is characteristically associated with hepatic carcinoma, but it has also been implicated 
in tumourogenesis of the lung following both ingestion and inhalation of the toxin 
(Donnelly al., 1996; Desai al., 2003).  Whereas cytochrome P450 plays the major role in 
the bioactivation of AFB1 in the liver, in the lung the main mediators in the conversion of 
AFB1 to the epoxide are lipoxygenase and prostaglandin H synthase. 
 
AFB1 has also been implicated in other diseases, for example Reye‟s syndrome (Trauner et 
al., 1984) and Kwashiorkor (Hendriekse et al., 1982).  Reyes‟s syndrome is a children‟s 
disease that attacks all organs of the body, but in particular the liver and brain. If left 
untreated this disease may progress into a deep coma, and finally death.  Fatality of this 
disease is common, up to as many as 40% of all cases.  Kwashiorkor, again, is a childhood 
disease, most common in developing countries, and is caused by inadequate intake of 
proteins. Symptoms include an extended abdomen and a reddish discolouration to the hair.   
Although this disease can be treated simply by adding protein to the diet, mortality can be 
as high as 60% or can result in arrested mental development.    
 
Aflatoxin has also been strongly linked to immunosupression, and has been shown in many 
livestock animals. Poultry (chickens and turkeys), pigs and lambs in particular are at risk 
from immunosuppression caused by aflatoxins (Devegowda and Murphy, 2005; Smith et 
al., 2005). Although the mechanisms of how aflatoxins do this is unknown, studies have 
shown that animals fed with aflatoxins show a decrease in specific antibody production and 
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the phagocytic activity of macrophages also falls.  A reduction in both humoral and cell 
mediated immunity decreases the resistance to infectious diseases.  This is most relevant for 
people in the developing world where depressed immunity caused by dietary aflatoxin 
intake increases the risk of contracting infectious diseases such as HIV and tuberculosis.  
 
Reduced immunity to animals can lead to reduced weight and growth and reduced egg and 
milk production  These have implications for the farmer e.g. losses in productivity.  
Aflatoxin has also been shown to be teratogenic in rats, mice and hamsters, promoting 
miscarriage and, thus, reducing normal birth rates. 
1.9  Aflatoxin prevention 
 
Aflatoxin contamination, under favourable conditions, is unavoidable.  However, several 
methods can help reduce the amount of aflatoxin generated.  The simplest way of reducing 
exposure to aflatoxins is improved storage, as most contamination occurs post-harvest.  An 
intervention study in West Africa showed that by employing simple post-harvest methods, 
a drastic reduction in the blood marker aflatoxin-albumin was observed (Turner et al., 
2005).  These methods included basic procedures to reduce fungal growth, such as hand 
sorting, sun drying on mats, storage in natural-fibre bags and using wooden pallets to raise 
the bags from the ground. 
 
Aflatoxin can be reduced in animal feeds by either physical or chemical means.  Physical 
methods include heat, microwaves, gamma rays, X-rays, UV light and adsorption.  
Adsorption methods involve the addition of inert chemicals to feed that are able to 
physically bind to aflatoxin (Philips et al., 1999).  The binding prevents the aflatoxin from 
becoming absorbed across the intestinal tract, and the aflatoxins, therefore, are passed out 
of the body via the faeces.  Adsorbents include some aluminosilicates (Scheideler, 1993), 
polymeric glucomannan (a compound extracted from yeast cell walls) (Karaman et al, 
2005), and chlorphyllin, a chemical closely related to chlorophyll (Simonich et al, 2007).   
 
AFB1 also binds to a number of different strains of lactic acid bacteria (LAB) (Haskard et 
al., 2001; Gratz et al., 2004).  LAB are probiotic bacteria found in healthy intestinal 
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microflora and have a positive effect on the removal of mutagens in the gut.  AFB1 binds 
non-covalently and extra-cellularly to the cell wall polysaccaride and peptidoglycan.  This 
also has potential for future applications to remove AFB1 from animal feed.  The most 
successful way, however, of reducing aflatoxins in feed is ammoniation which reduces 95 – 
98% of AFB1.  This method, however, is used only for animal feed, and is not used for 
food to be consumed by humans.  Methods used in developing countries to reduce aflatoxin 
contamination include par boiling rice and roasting pistachios in lemon juice.  Diet can also 
be important – both vitamin A (retinol), zinc, iron and selenium seem to alleviate the 
effects of aflatoxin B1.  A low protein diet also has been shown to reduce the 
carcinogenicity of AFB1.  In a study using Fischer rats, Youngman et al. (1992) compared 
aflatoxin-induced liver tumour development with rats fed a 5% (w/v) casein diet compared 
with those fed a 20% (w/v) casein diet.  The experiment showed that animals fed with the 
high protein diet had an approximately six times greater risk of developing a tumour on the 
liver.  This research seems to contradict findings that a low protein diet in humans actually 
accelerated aflatoxin carcinogenesis in the case of people suffering from Kwashikor.  It has 
been shown, however, that a low protein diet enhances the acutely toxic aflatoxin lesion but 
depresses the carcinogenic lesion (Appleton et al., 1983). 
 
Chemoprotection is also being examined as a means to reduce AFB1-induced HCC in areas 
with high instances of hepatitis B, as well as high AFB1 contamination risk.  An example of 
this is the anti-schistosomal drug Oltipraz (4-methyl-5-[N-2-pyrazynil]-1,2-dithiole-3-
thione) (Bammler et al., 1999).  Rats treated with Oltipraz have shown resistance to the 
development of liver tumours (Buetler et al., 1996).  Although the mechanism is largely 
unknown, experiments have been undertaken with marmosets, as they have similar 
oxidative profiles to humans (Bammler et al., 2000).  Results have shown that Oltipraz 
reduces AFB1 activation by inhibiting cytochrome P450 and decreasing AFB1-DNA adduct 
formation, and it also slightly induces glutathione S-transferase.  These three mechanisms 
in combination can all protect against AFB1-induced mutagenicity.   
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1.10  Legislation and regulatory limits for aflatoxins 
 
In an attempt to limit exposure to aflatoxins many countries (approximately 100) have 
imposed regulatory limits for aflatoxins levels in both food and animal feed.  Limits are 
selected to ensure adequate protection against the toxin, but are also designed to minimise 
the large negative impact on trade. Regulations are based on the known toxicology of the 
toxin.  The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has recently 
evaluated the toxicity of aflatoxin.  The typical end result of this is a regulation based on 
the Provisional Tolerable Weekly/Daily Intake (PTW/DI), which has been evaluated using 
the No Observable Adverse Effect Level (NOAEL).  The NOAEL is based on animal 
toxicology studies, incorporating an uncertainty factor of 100 – an extrapolation of 10 from 
animals to humans, and then a factor of 10 for the variation of an individual.  However, in 
the case of aflatoxins, when their carcinogenicity has been proven, the level of the 
contaminant has to be As Low As Reasonably Achievable (ALARA).  The ALARA 
principle is applied when the contaminant is ubiquitous and cannot fully be removed from 
the food.  The aim is to exclude as much of the toxin as possible from the food supply 
(FAO Corporate Document Repository, 2004). 
 
International limits for aflatoxins have yet to be harmonised, but the Codex Alimentarius 
Commission has suggested guidelines.  The Food and Agriculture Organization of the 
United Nations (FAO), and the World Health Organization (WHO) established the Codex 
Alimentarius jointly in 1963 to protect consumers‟ health and fair trade, and to help 
establish coordinated regulations.  In addition to the Codex regulations, many countries 
have set their own limits.  However, there can be quite a large discrepancy between the 
regulatory limits in different countries (Figures 1.3 and 1.4).  For example, limits for food 
for direct human consumption can range between 1 and 20 parts per billion (ppb) for 
aflatoxin B1 and between 0 and 35 ppb for total aflatoxins. 
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Figure 1.3 Graph showing the worldwide limits for aflatoxin B1 in food 
The limits for aflatoxin B1 worldwide range from 1ng/g to 20ng/g.  The most general 
limit for aflatoxin B1 in food worldwide is 2ng/g (FAO Corporate Document Repository, 
2004) 
 
The regulations of some countries are more comprehensive than others (Table 1.2).  For 
example Australia and New Zealand have only one specific regulatory limit set, for peanuts 
and tree nuts at 15μg/kg total aflatoxins.  All other foods have been set at 5μg/kg.  The 
most complete set of regulations including coverage of the largest range of foodstuffs and 
feed was set by the EU.  This was most recently updated in 2006 when new regulations 
were set By the European Commission for aflatoxin B1 in infant formula.  It was set at 0.05 
µg/kg (Commission Regulation (EC) No 1881/2006). 
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Figure 1.4 Graph showing the worldwide limits for total aflatoxins in feed 
The limits for total aflatoxins worldwide range from 0ng/g to 35ng/g.  The most general 
limit for aflatoxin B1 in food worldwide is 4ng/g (FAO Corporate Document Repository, 
2004)..   
 
 
Some countries (such as the US and Canada, following Codex guidelines) have set limits 
for total aflatoxins only, whereas other countries (for example members of the EU) have 
regulations for both total aflatoxins and aflatoxin B1.   
 
Apart from Europe other countries from the same geographical area have similar limits. In 
Latin America, for example, the aflatoxin regulations have been harmonized through a 
trading block of countries, MERCOSUR (Mercado Comun del Sur), which comprises 
Argentina, Brazil, Paraguay and Uruguay, although other countries also follow these 
regulations. Brazil and Uruguay have applied additional regulations to certain matrices.  
Africa has 15 countries that have regulatory limits set for mycotoxins, most of which 
include limits for aflatoxins. 
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ASEAN (Association of Southeast Asian Nations), consisting of Brunei Darussalam, 
Cambodia, Indonesia, Lao People‟s Democratic Republic, Malaysia, Myanmar, the 
Philippines, Singapore, Thailand and Vietnam, do not have harmonised regulations.  These 
countries all have specific regulations, the most strict of which was set by Singapore. 
 
Milk and milk products, including infant formulae, are a staple food for babies and young 
children, who are highly susceptible to the adverse effects of AFB1.  Some countries, 
therefore, have enforced stringent regulatory limits to protect those most at risk.  The 
lowest limits that have been set for AFB1 have been for infant formula by the EU.  The 
limits have currently been set at 0.1ppb (0.1μg/kg). 
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Table 1.2 Comparison between worldwide aflatoxin regulations 
Regulatory limits for aflatoxin can vary greatly between different foods and at different places around the world.  This table 
highlights how greatly the regulations can vary (FAO Corporate Document Repository, 2004).. 
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1.11  Methods of Analysis 
The establishment of regulatory limits for aflatoxin has necessitated reliable and sensitive 
analytical methods of detection and analysis.  Several official or regulatory laboratories 
have already validated numerous methods.  These organisations include the Association of 
Official Analytical Chemists (AOAC), the International Union of Pure and Applied 
Chemistry (IUPAC), International Organisation for Standardisation (ISO), and its European 
counterpart the European Committee for Standardisation (CEN). 
 
The first methods that were validated to test for mycotoxins used thin layer 
chromatography (TLC).  Aflatoxin has a natural fluorescence, and so can be detected using 
UV light. These methods are simple and cheap, but they are insensitive and lack precision 
(repeatability and reproducibility).  They have been overtaken by other chromatographic 
methods, such as High Performance Liquid Chromatography (HPLC) (improved by 
derivatisation with bromine) (Dunne et al., 1993; Zhang et al., 2004; Seuva et a.l, 2005), 
HPLC/MS (HPLC/mass spectrometry) (Biancardi et al., 2005) LC-MS/MS (Liquid 
Chromatography/Mass Spectrometry/Mass Spectrometry) and GC/MS (gas 
spectrometry/MS) (Sforza et al., 2005; Cavaliere et al., 2006).  These methods are more 
sensitive than TLC, but are time consuming, labour intensive and require skilled training.  
They also require high consumption of hazardous solvents, and, so, are often expensive.  
Therefore, they are unsuitable for the analysis of large numbers of samples. 
 
More recently, however, the advent of immunoassays has had a significant impact on 
aflatoxin detection and quantification.  Immunassays are simple, quick and cheap to apply 
for routine monitoring of aflatoxin contamination.  These can then be checked by an 
analytical method, such as HPLC.  Immunological assays can come in many different 
formats – e.g. ELISA (enzyme-linked immunosorbant assay) (Reddy et al., 2000; 
Gathumbi et al., 2003) and lateral flow strips (Sibanda et al., 1999; Blesa et al., 2003).  
These methods are ideal for screening large numbers of samples, but they can suffer from 
matrix interference depending on the food type being tested and they lack the sensitivity of 
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detecting aflatoxin B1 as low as the regulatory limits, especially for limits as low as 0.1ppb 
for infant formula. 
 
Another immunological method that have become increasingly popular is the use of 
immunoaffinity columns (IAC‟s) (Stroka et al., 2000; Senyuva et al., 2005; Castegnaro et 
al., 2006; Ip et al., 2006).  Immunoaffinity columns have been used for aflatoxin isolation 
from complex matrices prior to analysis.  They consist of antibodies immobilised onto a 
stationary phase (e.g. sepharose).  When a sample is passed through the column all the 
aflatoxin binds to the antibodies and remains in the column.  The other components from 
the sample, however, are washed through the column and discarded.  The aflatoxins are 
then eluted from the column with a solvent, resulting in a pure solution of aflatoxin, which 
can then be quantified using HPLC or GC methodology.  IAC‟s are simple to use and 
drastically reduce sample preparation time.  One drawback, however, is that they can be 
relatively expensive and generally cannot be re-used efficiently.  
 
There are also several automated systems in development that can detect and quantify 
aflatoxins that are not yet commercially available, each utilising a different innovative 
technology.  These include optical waveguide lightmode spectropscopy (Adanyi et al., 
2007), sol particle immunoassay (Brenn-Struckhofova et al., 2007), fluorescence 
polarisation (Nasir et al., 2002), affinity electrochemistry (Mascini et al., 2001), fluid 
based-bioaerosols and surface plasmon resonance (SPR) (Daly et al., 2000; Maragos et al., 
2002; Dunne et al., 2005). Surface plasmon resonance was chosen as the sensor detection 
system for the study of aflatoxin determination in this research. 
1.12  Surface Plasmon Resonance 
 
Surface Plasmon Resonance (SPR) is an optical technique that can measure biomolecular 
interactions, allowing detection and quantification of specific analytes in a solution.  
Although several commercial systems are available, the most universal is Biacore
TM
, who 
have established a clear leadership in SPR technology, holding approximately 90% of the 
market (Figure 1.5).   
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Figure 1.5 The Biacore
TM
 Surface Plasmon Resonance System 
The Biacore
TM
 system combines SPR technology with a unique microfluidic system and 
innovative biosensor chip technology using comprehensive wizard driven software.  
(Image courtesy of Biacore
TM
) 
 
 
 
SPR occurs at the interface between two media of different refractive index.  In the case of 
Biacore
TM
, these media are the glass of the sensor chip and the sample solution. When the 
beam of light passes from a dense to a less dense medium the light bends towards the plane 
of the interface.  However, when the angle of incidence is at a critical angle, none of light is 
refracted across the interface, but is reflected internally.  This is called the total internal 
reflection (TIR).  At this point, an electromagnetic field penetrates a short distance, about 
half the wavelength of the incident light i.e. tens of nanometres, into the lower density 
media, the sample solution.  This creates an evanescent wave, with an amplitude that 
decreases exponentially with increased distance from the interface surface (Liedberg et al., 
1993). 
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Figure 1.6 Surface Plasmon Resonance 
When a sample is passed through the flow channel specific antigens (if present in the 
sample) will bind to the antibody coated surface.  This causes a shift in the resonance 
angle of the refracted polarised light shone onto the chip. This change in angle is directly 
proportional to the amount of bound antigen.  (Image courtesy of Biacore
TM
) 
 
If the interface is covered with a thin layer (50nm) of a metal (usually gold), and the light is 
p-polarized and monochromatic, under conditions of TIR, photons react with the free 
electron cloud in the metal and are converted into surface plasmons, the particle name of 
electron density waves.  
 
The evanescent wave field penetrates the sample solution.  It is, therefore, sensitive to 
solute concentration at that point and the binding of molecules from the sample onto the 
gold surface can cause changes in the refractive index.  This is measured as a change in 
resonance angle and is directly proportional to the amount of biomolecules bound.  The 
shift in resonance angle is directly proportional to the mass increase on the chip surface. 
 
The change of angle, or the response, is measured in arbituary units, Resonance Units (RU), 
where 1 RU is equivalent to a shift in angle of 0.0001º (Huang et al., 2007). For most 
proteins this is a change in concentration of 1pg/mm
2 
on the sensor surface. 
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1.13  Sensor Surface 
 
In the Biacore
TM
 system, the sensor surface is a removable, re-usable sensor chip, 
consisting of a glass surface coated with a thin layer of gold (50nm) at the interface 
between the glass and the buffer (Figure 1.7).  A variety of other metals can be used for 
SPR.  To be suitable for SPR a metal‟s conduction electrons must be able to resonate with 
light at a particular wavelength, generally in the visible and near infrared parts of the 
spectrum, as there are a number of detectors readily available for these regions.   
Appropriate metals include aluminium, silver, copper, sodium, indium and gold.  Gold has 
been chosen as the ideal candidate as it is inert and resistant to oxidation, while still 
allowing the attachment of antibodies.  It also produces a strong SPR signal in the near-
infrared region.   
 
 
 
 
Figure 1.7 Biacore
TM
 CM5 Sensor Chip 
The sensor chip consists of gold-coated glass surface.  A linker layer is coated onto the 
gold.  In the case of the CM5 chip it is carboxymethylated dextran.  The dextran layer 
then facilitates the attachment of the coupling surface.  In this assay the coupling 
surface consists of the aflatoxin B1 derivative aflatoxin B1-oxime-ethylenediamine. 
 
 
To measure binding of molecules at the sensor surface one of the binding partners must be 
immobilised onto the gold surface, which is facilitated through covalent attachment.  The 
most commonly used and versatile chip, the Sensor Chip CM5, is coated with a 100–200nm 
carboxymethylated dextran layer.  This dextran hydrogel layer is hydrophilic and allows 
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attachment of molecules via amine, thiol, aldehyde, hydroxyl or carboxyl groups, without 
causing them to denature (Shankaran et al., 2007).  The sensor surface is generally very 
stable, which allows it to be reused hundreds of times whilst still maintaining high 
precision and accuracy in many cases. 
1.14  Microfluidic System 
 
Another feature of the Biacore
TM
 system is the unique microfluidic system, which allows a 
continuous and controlled flow of liquid over the sensor surface.  When the sensor chip is 
docked in the instrument, it is pressed against the integrated microfluidic cartridge (IFC) 
and four flow cells are formed, which range in size from 20 to 60nl, depending on the 
model of the instrument.  The analyte is then able to flow continuously at a constant 
concentration over any one of the flow cells. The sample volumes can be in the range of 5 
to 450μl and with a flow rate of between 1 and 100 μl/min.  This system has numerous 
advantages.  These include the exclusion of air from the chip surface thus preventing 
protein denaturation or sample evaporation, low sample consumption and the removal of 
the necessity for washing steps. 
 
The models Biacore-Q and Biacore-1000 only allow the monitoring of one flow cell at a 
time.  Biacore 2000 and Biacore 3000, however, allow a sample to pass over the four flow 
cells sequentially, following the response from all four flow cells in parallel.  This means 
that four different assays can potentially be performed on one sample in the same run. 
1.15  Surface Plasmon Resonance Sensorgrams 
 
The association and disassociation of analytes in the sample binding to the sensor chip 
surface is followed, in “real-time”, on a graph, called a sensorgram.  The sensorgram 
measures changes in response units (RU) over time, where one thousand RU is equivalent 
to approximately 1ng of analyte bound to the chip surface. 
 
When a sample is injected over the chip surface, there is an interaction between the 
molecules in the sample and the flow cell surface.  If the binding molecules are present, 
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they will associate, resulting in a rise in the sensorgram.  Once the reaction has reached an 
equilibrium the sensorgram will remain constant.  After the sample is injected, buffer is 
passed over the chip surface and the interacting partners dissociate, causing the sensorgram 
to fall.  Not all of the analyte may dissociate from the chip surface, necessitating a 
regeneration step to return the sensorgram to the baseline before another sample is injected 
(Figure 1.8). 
 
 
 
Figure 1.8  SPR Sensorgram 
If there are binding molecules in a sample there will be an association on the chip 
surface which result in a rise in the sensorgram.  When the reaction has reached 
equilibrium the sensorgram will remain constant.  Once the sample injection has 
finished buffer will be injected over the surface.  At this point some of the interacting 
proteins will dissociate, as shown by a drop in the sensorgram.  Ten seconds after the 
sample injection has finished the concentration of the sample bound to the surface is 
recorded.  This is point is shown as an “X” on the diagram.  To remove all the bound 
material a regeneration step is introduced.  (Image courtesy of Biacore
TM
) 
 
 
The sensorgram shows binding between the immobilised target and its corresponding 
ligand and can be used for kinetics, e.g. calculating association/disassociation rates.  It can 
also show how strong the affinities of the interacting partners are. 
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1.16  Inhibition Assays 
 
The smallest molecule that can be detected using SPR in the configuration described is 180 
Da.  Therefore, this is not sufficiently sensitive to detect small molecules such as toxins and 
drug residues in a direct assay format.  For low molecular weight analytes the assays are 
formatted as inhibition assays.   In this format the analyte (or its derivative) is immobilised 
onto the chip surface.  Prior to injection a fixed amount of aflatoxin binding protein is 
mixed with the sample.  Any analyte in the sample will bind to the binding protein and 
inhibit it from binding to the surface of the sensor chip when the sample is passed over it.  
The higher the concentration of the analyte in the sample, the higher the level of inhibition 
and hence the lower the response of the biosensor.   A calibration curve is generated using 
the responses produced from known standards.  The amount of analyte in a sample can then 
be quantified in reference to this curve as shown in Figure 1.9. 
                                       
 
Figure 1.9  Inhibition Assay for Aflatoxin B1 Determination 
A mixture of sample and antibody is passed over the sensor chip surface.  Any analyte in 
the sample will sequester antibody and prevent it from binding to the surface.  The 
higher the amount of analyte in the sample, the higher the level of inhibition and, 
therefore, the lower the response on the sensorgram (Image courtesy of Xenosense Ltd.). 
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1.17  Binding Protein used in SPR assays 
 
Binding proteins are proteins that are known to bind to a specific target protein.  The 
sensitivity and the specificity of an assay is largely dependant on the specificity and 
strength of the binding protein to the target.   Other requisites for the binding protein are 
that it must be stable and robust, and that it can be immobilised onto the chip surface. 
 
 
The binding proteins most often used in bioassays are antibodies.  Antibodies are useful 
tools as they can be easily raised against a particular target and are capable of very specific 
recognition and high affinities.  The basic structure of an antibody is depicted in fig 1.10. 
An antibody is made up of two identical heavy (H) and two identical light (L) chains which 
are joined together by disulphide bonds.  A heavy chain has a molecular weight of 50kDa 
and has one variable region VH and three constant regions CH1, CH2 and CH3.  The light 
chain has a molecular weight of 25kDa and consists of one variable and one constant 
region, VL and VH.  It is the variable regions of the heavy and light chains that together 
form the antigen binding site (Conroy et al., 2009). 
 
 
Figure 1.10 Structure of an antibody made up of two identical heavy and two identical 
light chains.  A heavy chain is made up of one variable region (VH) and three constant 
regions (CH1, CH2 and CH3).  A light chain comprises of one variable region (VL) and 
one constant region (CL).  The antigen binding sites are indicated by the triangles and 
the disulphide bridges are indicated by red lines (Conroy et al., 2009) 
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Antibodies used in assays can either be polyclonal, monoclonal or recombinant.     
Polyclonal antibodies are produced when an antigen is injected into a suitable host, e.g. 
mouse, rabbit, goat or rat.  This induces the B-cells of the immune system to produce 
antibodies specific for that antigen.  Each B-cell produces a slightly different antibody, 
either with different specificities or targeting different epitopes on the antigen.  Therefore, 
when serum from the animal is removed and purified it will contain a mixture of antibodies, 
with varying affinities for the original injected antigen (Conroy et al., 2009). 
 
Monoclonal antibodies, however, are derived from a single B-cell and, so, are identical.  In 
the generation of monoclonal antibodies B-cells from the spleen or the lymph nodes of an 
animal that was immunised with the antigen several times, are removed.  The B-cells are 
then fused, either by electroporation or using polyethylene glycol, to myeloma tumour 
cells.  Myeloma tumour cells are cancerous B-cells that are able to grow indefinitely, but 
have lost the ability to produce antibodies.  When the two cells are fused, a hybridoma cell 
is produced, which is capable of reproducing quickly and indefinitely, generating large 
amounts of identical antibody to the target antigen (Maragos et al., 2000). 
 
The use of recombinant antibodies, however, has become increasingly more popular due to 
advantages over both monoclonal and polyclonal antibodies.  The production of 
recombinant antibodies, for example, does not necessarily require the use of animals to 
produce an antibody library. Naïve libraries can be produced using pooled blood samples 
from humans.  However, for certain applications immunisation of animals is necessary 
where antibodies to the required target are not naturally found in the blood.  This is the case 
for toxins such as aflatoxins and would generate an immune library that would contain 
more antibodies specific to the target. Other advantages of recombinant antibodies are that 
they are theoretically far quicker than either monoclonal or polyclonal to produce, and can 
also be used for antigens unsuitable for conventional antibody production, for example if 
the antigens are non-immunogenic or are extremely toxic to the animal.  However, the 
primary advantage of utilising recombinant antibody technology is that the engineered 
antibody fragments can be manipulated to improve their sensitivity, cross-reactivity and 
robustness.  
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Recombinant antibodies are artificially produced through the manipulation of genetic 
material.  RNA, extracted from B-lymphocytes, is reverse transcribed and amplified by 
PCR to produce a synthetic library of recombinant antibodies.  Several types of 
recombinant antibody can be made, including single chain antibody fragments (scFv) and 
Fab fragments (Morea et al., 1997).   
 
To generate an antibody to a specific antigen an antibody library must go through several 
rounds of screening.  An example of a robust high-throughput screening procedure is phage 
display.  Phage display was first described by Smith and co-workers in 1985 (Smith, 1985).  
They had discovered that when a protein is cloned into the PIII gene of the filamentous 
phage M13 it will be displayed on the phage coat surface as a fusion protein.  A library of 
antibody fragments of up to 10
10
 can be cloned into the phage genome (Hoogenboom, 
2005).   
 
 
 
 
Figure 1.11  Diagram showing structures of a Fab fragment and an scFv compared to a 
typical IgG molecule.  A Fab fragment consists of a heavy and a light variable region, VH 
and VL, which comprise the antigen binding site.  Their structure also includes the 
constant regions of the heavy and light chains, CH and CL.  An scFv, however, consists of 
only the VH and VL domains joined together by a (Gly4Ser)3 linker (Conroy et al., 2009). 
 
Antibody 
molecule 
  Fab fragment    scFv 
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A scFv comprises of a VH and a VL domains of an antibody joined by a (Gly4Ser)3 linker.  
The glycine/serine rich sequence does not form secondary structures and is also beneficial 
as it is found naturally in the M13 PIII gene and is therefore tolerated in phage display 
(Conroy et al., 2009).   
 
Fab fragments, in addition to the VH and the VL sections, contain constant regions of the 
heavy and light chains, CH and CL.  Although Fab are more stable and less likely to 
dimerise, scFv libraries tend to be more popular because the expression of the smaller scFv 
on the phage surface has a less toxic effect on the cell, thus resulting in a better yield and, 
therefore, library diversity (Arndt et al., 2001). 
 
To isolate an antibody that binds specifically to the target protein, or antigen, usually 
requires between two and five rounds biopanning (Figure1.11). The system works on the 
principle that the phage displaying the antibody that shows affinity towards the target also 
contains the genetic material that encodes it, thus linking the antibody‟s phenotype with 
genotype.   
 
The mixture of phage, each presenting an antibody from the library is added to a microtitre 
plate coated with target protein.  The plates are then washed and any phage-antibodies that 
bind to the target remain associated to the surface.  Binders are then eluted, and then used 
to produce more phage.  This phage mixture will be “enriched” containing a higher 
percentage of binders.  The enriched mixture is then used for further rounds of biopanning.   
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Figure 1.12 Schematic drawing of phage display and bio-panning.  The DNA antibody 
library is ligated into a specific part of the phagemid genome.  The antibody fragment is 
then expressed as a protein on the phage coat surface.  The antigen is immobilised onto 
the surface of a microtitre plate.  The library of phage displaying antibody on the coat 
surface are added to the plate and incubated to allow the phage to bind.  Non-binders are 
washed away.  Attached phage are then eluted and then re-infected into E.coli cells.  The 
phage can then go through another round of biopanning (Wittrup et al., 1999). 
 
1.18  Aim of Project 
 
The aim of this project was to design a SPR sensor-based diagnostic method to measure 
Aflatoxin B1 in a wide range of foodstuffs and animal feed.  The kit will be designed 
specifically for use on a Biacore analyser, which utilises the latest SPR technology. 
 
This project was partially funded through the FUSION Programme, which is co-ordinated 
by InterTradeIreland.  The purpose of FUSION is to establish collaborative 3 way cross 
border partnerships between technology-based private companies, knowledge centres (such 
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as universities and colleges) and recent graduates.  The strategy is to facilitate technology 
and knowledge transfer from universites to businesses, in order to introduce innovation, 
increase their capabilites, and, thus, gain competitive advantage.  This project was a joint 
venture between Xenosense Ltd and Dublin City University. 
 
XenoSense Ltd. is a Belfast based biotech company which develops and manufactures in 
vitro diagnostic kits for use in food safety and quality assurance applications.  The kits have 
been designed specifically for use on optical biosensors produced by the Swedish company, 
Biacore
TM
, which harness innovative SPR and sensor chip technology.  Xenosense 
currently has a repertoire of 13 kits that fall into two categories – vitamins and drug 
residues.   
 
Xenosense, as a new and expanding company, is eager to explore and break into different 
market sectors.  The global market share for mycotoxins is estimated at approximately £75 
–100 million, with rapid diagnostic methods accounting for 10 – 20% of this (CAST report, 
2003).  This is a fairly new market, the average annual growth is high at 10%.  Aflatoxin B1 
was chosen to be the pilot assay for development as it is the most well known mycotoxin 
and has the most complete regulatory limits compared to other mycotoxins.  There are 
already a number of competitors in the market.  However, due to changing legislation 
demanding increased testing and the ability to detect lower levels, this sector is growing 
fast.  There is niche in this market for high-throughput, automated systems that are sensitive 
enough to meet the demands of the recently lowered regulatory limits.  This project, to 
develop an assay for aflatoxin B1, will be a springboard into this market, and will give 
Xenosense the opportunity to expand their portfolio further still, by producing other kits to 
detect different mycotoxins. 
 
1.19  Objectives 
 
The overall objectives for the experimental research of the project could be summarized as 
follows. 
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1. Development of a sensor chip surface 
A previous study had shown the most effective way to immobilise aflatoxin B1 onto the 
sensor chip surface.  The first objective was to recreate this and prove the efficacy by 
injecting over the surface an excess of antibody specific to aflatoxin B1. 
 
2. Prove the feasibility of an aflatoxin B1 assay in buffer 
The next objective was that a standard curve for aflatoxin B1 could be generated in a buffer 
system. 
 
3. Evaluation of different antibodies that are specific to aflatoxin  B1 
Antibodies were supplied to us by Professor Richard O‟Kennedy, School of Biotechnology, 
Dublin City University as part of the FUSION programme.  These antibodies had to be 
tested individually to determine which one would be most suitable for the assay.  A series 
of curves had to be set up using all four antibodies added in various percentage fractions, 
and different injection times, to determine the most sensitive antibody and assay conditions. 
 
4. Choose which food matrices to investigate 
Aflatoxins contaminate a large and diverse range of foodstuffs.  Ultimately this assay is to 
be marketable and therefore matrices chosen depend on a number of factors.  For example, 
what other tests are currently available on the market, what the unique selling point of the 
assay will be and what matrices would be beneficial to existing customers of Xenosense 
Ltd. 
 
5. Produce a sensitive and reliable assay  for each matrix 
 
A quick and simple extraction method would then need to be developed for each matrix.  
To do this the matrix is spiked with a known amount of aflatoxin B1 and then extracted.  
The amount recovered could be calculated by running the extract against the aflatoxin B1 
standard curve.   
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6. Validation 
The final objective for this product was to validate the assay(s).   This would be required if 
the test was to go on the market. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: 
Materials 
and 
Methods 
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2.1 Suppliers 
 
Table 2.1 List of suppliers for raw materials, consumables and equipment 
Supplier Address 
Albion Chemicals Albion House, Rawdon Park, Green Lane, Yeadon LS19 
7XX, UK. 
BD Plastipak Edmund Halley Road, Oxford OX4 4DQ, UK. 
BDH 603a Dalamal Chambers, New Marine Lines, Mumbai, 
400 020, India. 
Biacore AB Rapgatan 7, SE754 50, Uppsala, Sweden. 
BOC Group Prince Regent Road, Belfast BT5 6RW, Northern Ireland 
Chromacol 3 Mundells Industrial Centre, Welwyn Garden City, Herts 
AL7 1EW, UK. 
Denver Instruments Robert-Bosch-Breite 10, 37079 Gottingen, Germany. 
Eppendorf Barkhausenweg 1, 22339 Hamburg, Germany. 
Fermentek Yatziv25, POB47120, Jerusalem 97800, Israel. 
Gilson 3000 Parmenter Street, P.O. Box 620027, Middleton 
WI53562-0027, USA. 
Greiner 7 Rue Leo Lagrange, F-27950 Saint Marcel, France. 
Kimberley Clark P.O. BOX 619100, Dallas, Texas, USA. 
KNF Neuberg D-79112 Freiberg, Germany. 
Nalgene Ridderstraad 26, B3040 Neerijse, Belgium.  
Prolabo 54, rue Roger Salengro, 94126 Fontenay-sous-bois Cedex, 
France. 
R-Biopharm Rhone West of Scotland Science Park, Unit 3.06, Kelvin 
Campus, Glasgow G20 0SP, Scotland. 
Scientific Industries Inc Bohemia, New York, 11716, USA. 
Sigma Aldridge Fancy Road, Poole, Dorset BH12 4QH, UK. 
Stuart Scientific Beacon Road, Stone, Staffordshire ST15 0SA, UK. 
Techne 3 Terri Lane, Suite 10, Burlington, NJ 08016, USA. 
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Vicam 313 Pleasant Street, Watertown, MA 02472, USA. 
Whatman Springfield Mill, James Whatman Way, Maidestone, Kent 
ME14 2LE, UK. 
Wishart Group Milewater House, Mill Road, Ballyclare, County Antrim, 
BT39 9DY. 
 
 
2.2 Materials  
2.2.1 Chemicals 
 
Table 2.2  List of chemicals used with the supplier and the catalogue number  
Chemical Supplier Catalogue number 
Acetone HPLC grade BDH 15296 6P 
Acetonitrile HPLC grade BDH 15285 6K 
Aflatoxin B1 Fermentek AF 
Bovine Serum Albumin (BSA) Sigma Aldridge 054KD607 
Chloroform HPLC grade BDH 152835F 
Cyclohexane HPLC grade BDH 1528965 
Di-sodium hydrogen 
orthophosphate anhydrous, GPR 
BDH 301584L 
Ethylenediamine Biacore AB 22-0526-55 
Ethanol (min 99.7%, v/v), 25L Albion Chemicals Se 3033 
Guanidine hydrochloride (99%, 
w/v) 
Sigma Aldridge G4505 
HBS Biacore AB 22-0527-06 
HBS EP+ Biacore AB BR-1006-69 
Hydrochloric acid (2.0M) Merck HC753278 
Methanol (HPLC grade) BDH 15250 
Monoclonal anti-Aflatoxin B1 
antibody (mouse-derived) 
Sigma A9555 
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N,N'-dicyclohexyl-carbodiimide Biacore AB 22-0526-54 
N-hydroxysuccinimide Biacore AB 22-0526-53 
Nitrogen (“oxygen-free”) BOC Size W 
O-(carboxymethyl)-hydroxylamine 
hemi-hydrochloride 
Sigma Aldridge A4508 
Pyridine Prolabo 27 197.238 
Sodium azide, AnalaR BDH K35580906 605 
Sodium chloride, AnalaR BDH 102415K 
Sodium hydrogen carbonate Sigma Aldridge 236527 
Sodium hydroxide, 0.1M, (ConvoL), 
6pk 
BDH 18043 5A 
Sodium hypochlorite solution GPR BDH 3016965 
Sodium phosphate monobasic Sigma Aldridge S0751-100G 
 
2.2.2 Preparation of Buffers and Reagents 
 
0.1M 10X Phosphate Buffered Saline (PBS), pH 7.4,  
 
Sodium phosphate monobasic  2.3g 
Di-Sodium hydrogen    11.5g 
Sodium chloride    87.5g 
 
900ml of ddH2O was added and stirred until all salts had dissolved.  The pH was adjusted 
to 7.4 by addition of 1M HCl and then more ddH2O added to a final volume of 1l. 
 
0.1M NaOH:20% (v/v) acetonitrile regeneration solution  
 
1M Sodium hydroxide   100μl 
Acetonitrile     200 μl 
ddH2O      700 μl 
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6M Guanidine hydrochloride, pH 4 
 
Guanidine hydrochloride   114.64g 
ddH2O      180ml 
 
Adjust the pH to 4.0 with 1M HCl, then add ddH2O to a final volume of 200ml. 
 
Antibody storage solution 
BSA      0.5g 
Sodium azide     0.195g 
HBS buffer     200ml 
 
HBS-EP (produced by Biacore
TM
) 
0.01M HEPES, pH 7.4 
0.15M NaCl 
2mM EDTA 
0.005% (v/v) Surfactant P20 
 
2.2.3 Consumables 
 
Table 2.3 List of consumables and details of where they were purchased 
Consumable Supplier Catalogue number 
„Easi-extract‟ aflatoxin 
immunoaffinity columns 
R-Biopharm Rhone RP70N 
Aflatest immunoaffinity 
columns 
Vicam G1024 
Anotop 25 inorganic 
membrane filter (0.2μm) 
Whatman 6809-2024 
96 well plate Greiner M2186 
Foil plate sealers Biacore AB N/A 
7mm vials Gilson 2 9508 32 
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4ml glass vial (6mm) Chromacol 45V 
2ml plastic microtube Sarstedt 72.694 
4ml plastic Vial (6mm) Nalgene 215-0246 
2ml syringes BD Plastipak 300185 
CM5 sensor chips 
(Certified) 
Biacore AB 22-0310-03 
Latex gloves Kimberley Clark 112-0150 
Pipettes tips 100-5000µl Eppendorf 022492080 
Pipettes tips 50-1000 µl Eppendorf 022491555 
Pipettes tips 2-200 µl Eppendorf 022491539 
 
2.2.4 Equipment 
 
Table 2.4 List of equipment and details of where they were purchased 
Equipment Supplier 
Analytical balance (3 figure) IR-403 Denver Instruments 
Analytical balance (4 figure) Mettler 
Toledo 
Wishart Group 
Biacore Q instrument Biacore 
Concentrator (DRI Block DB 3D) Techne 
Magnetic stirrer Stuart Scientific 
pH meter (Ultra basic benchtop) Denver Instruments 
Pipettes (2-20μl, 20-200μl, 200-1000μl 
and 500-5000μl) 
Eppendorf 
Roller Mixer SRT2 Stuart Scientific 
Vacuum manifold Vac Master 
Vacuum pump ICNF Neuberg 
Vortex Scientific Industries Inc 
Refrigerated Centrifuge (5810R) Eppendorf 
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2.3     Methods 
 
2.3.1 Assay Development Methodology 
 
2.3.1a Preparation of aflatoxin B1-oxime-ethylenediamine 
 
1. Fifty mg aflatoxin B1 was dissolved in 10mls of pyridine and 80mg 
carboxymethyloxime hydrochloride added.   
2. The pyridine was evaporated under a stream of nitrogen and gentle heating to 
produce a brown oil. 9ml chloroform was added to the oil, followed by 1ml pyridine.   
3. The flask was then placed on ice and 32mg N,N'-dicyclohexyl-carbodiimide (DCC) 
and 20mg N-hydroxysuccinimide (NHS) added.  The reaction mixture was then 
stirred overnight at 4C.   
4. The next day it was decanted into an eppendorf tube.  It was then centrifuged on a 
benchtop microfuge at 18000g for 10 minutes, the pellet discarded and the solvent 
evaporated under a stream of nitrogen and gentle heating, and kept to one side.  
5. The remaining brown oil in the flask was dissolved in 2ml pyridine with 24mg DCC 
and 12mg NHS.   
6. The reaction was stirred for the rest of the day and overnight at room temperature.   
7. The mixture was again centrifuged at 18000g on a benchtop microfuge for 10 
minutes and the pellet was discarded.   
8. The solvent was added to the residue from step 4, and the solvent again was 
evaporated under nitrogen with gentle heating.  This resulted in the formation of a 
brown residue.   
9. Five ml of ethanol was added to the residue, and then a solution of NaHCO3 and 50µl 
ethylendiamine in 1ml water was added drop wise.  The reaction mixture was stirred 
all day and overnight at room temperature.   
10. The ethanol was then evaporated under a stream of nitrogen and gentle heating 
(70°C).   
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11. Two ml of methanol was added to the end product and it was purified by preparative 
TLC.  It was then dissolved in chloroform: methanol (7:3), and finally, the solvent 
was removed using a rotary evaporator.  The final product was a brown residue. 
 
2.3.1b Immobilisation of aflatoxin B1derivative, aflatoxin B1-oxime-ethylenediamine, onto 
sensor chip surface through amine coupling  
 
1. EDC (1-ethyl-3-(-3-dimethylamino propyl) carbodiimide hydrochloride) and NHS 
were mixed together 50:50.  50µl was added onto a research grade sensor chip.  It 
was left on at room temperature for 30 minutes, and then removed with tissue 
without touching the surface.   
2. Fifty µl of derivative was made up to a concentration of 2mg/ml with 0.1M borate 
buffer, pH 8.5, and incubated in darkness overnight. The solution was then removed 
with tissue paper.   
3. Fifty µl ethanolamine was added to the chip.  After a 30 minute incubation at room 
temperature, the solution was again removed with tissue paper.  Finally, the chip was 
washed with double deionised water and dried over a stream of nitrogen. 
 
2.3.1c Optimisation of the immobilisation of aflatoxin B1 derivative, aflatoxin B1-oxime-
ethylenediamine onto sensor chip surface through amine coupling  
 
1. EDC (1-ethyl-3-(-3-dimethylamino propyl) carbodiimide hydrochloride) and NHS 
were mixed together 50:50.  50µl was added onto a research grade sensor chip.  It 
was left on at room temperature for 30 minutes, and then removed with tissue paper 
without touching the surface.  
2.  Fifty µl of derivative was made up to a concentration of 2mg/ml with a 50:50 mix of 
borate buffer/CTAB (cetyl trimethyl ammonium bromide solution) and incubated in 
darkness overnight. The solution was then removed with tissue paper.   
3. Fifty µl ethanolamine was added to the chip.  After a 30 minute incubation at room 
temperature, the solution was again removed with tissue paper.  Finally the chip was 
washed with water and dried over a stream of nitrogen. 
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2.3.2 Compound Feed (IRMM Reference Material) Extraction Methodology 
 
2.3.2a Simple methanol extraction of aflatoxin B1 from compound feed 
 
1. One g aliquots of sample (9.3ng/g) were added to 10ml of 100% (v/v) methanol.   
2. The samples were vortexed and centrifuged for 10 minutes at 2000g.   
3. Eight ml of the samples were removed and the solvent evaporated in a concentrator 
(Techne) at 70°C over a steam of nitrogen.  An oily residue was produced and this 
was then reconstituted in 1ml of HBS.   
4. The samples were then diluted 1 in 2, 1in 3 and 1in 4 with HBS.  A calibration curve 
was produced using known amounts of aflatoxin B1 dissolved in HBS buffer.  The 
calibrants were 0, 0.5, 1, 2.5, 5, 10, 2.5 and 50ng/g of aflatoxin B1 and they were 
prepared in duplicate.   
5. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions consisted of  an antibody fraction of 30% (antibody and sample are mixed 
together by the biosensor at a ratio of 30:70) and an injection time of 480 seconds as 
these were found to be the optimal conditions.  The regeneration solution was 10mM 
NaOH and 20% (v/v) acetonitrile, with a 20 second injection time. 
 
 
2.3.2b Extraction of aflatoxin B1 from compound feed using “Mycosep” SPE (solid 
phase extraction) columns from Romer Laboratories 
 
1. One gram of compound feed (9.3ng/g) was added to an acetonitrile/water solution 
(8.4ml acetonitrile to 1.6ml water), vortexed and put on a roller mixer for 30 
minutes.   
2. The sample was centrifuged at 2000g for 10 minutes and 8ml was removed.   
3. The sample was then passed through the Mycosep column.   
4. Four ml of the eluate was them removed and evaporated over heat (70°C) and under 
a stream of nitrogen.   
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5. The sample was then reconstituted in 1ml HBS to make up a final concentration of 
3.72ng/g.  The sample was analysed against a calibration curve made up in either 
HBS buffer or blank extract. The calibrants were 0, 0.5, 1, 2.5, 5, 10, 2.5 and 50ng/g 
of aflatoxin B1 and they were prepared in duplicate.   
6. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions constitute an antibody fraction of 30% (i.e. the sample volume to antibody 
volume is 70 to 30) and an injection time of 480 seconds.  The regeneration solution 
was 10mM NaOH and 20% (v/v) acetonitrile, with a 20 second injection time. 
 
2.3.2c Extraction of aflatoxin B1 from compound feed using “Easi-extract aflatoxin” 
immunoaffinity columns from R-Biopharm Rhone 
 
The extraction procedure was followed as described in the protocol supplied with the 
columns.  An acetonitrile extraction is recommended for compound feed.   
 
1. Three 1g samples (2 blank and one low-level aflatoxin” sample (9.3ng/g)) were 
added to 10ml 60/40 acetonitrile/water solution.  The samples were vortexed and put 
on a shaker for 30 minutes.   
2. They were then centrifuged at 2000g for 10 minutes.   
3. Two ml was removed and added to 48ml PBS, pH 7.4.   
4. The columns were conditioned by passing 20ml of PBS through.   
5. The diluted samples were then passed through the columns and then washed with 
20ml distilled water.   
6. The aflatoxin B1 was then eluted by passing 1.5ml 100% (v/v) methanol through the 
column.   
7. The samples were dried in a concentrator at 70°C over a stream of nitrogen.   
8. The samples were then resuspended in 1ml HBS.  The sample was analysed against a 
calibration curve made up in blank sample extract. The calibrants were 0, 0.5, 1, 2.5, 
5, 10, 2.5 and 50ng/g of aflatoxin B1. 
9. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions constitute an antibody fraction of 30% (antibody and sample are mixed 
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together by the biosensor at a ratio of 30:70)  and an injection time of 480 seconds.  
The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, with a 20 
second injection time. 
 
2.3.2d Extraction of aflatoxin B1 from compound feed using “Aflatest” 
immunoaffinity columns from Vicam 
 
1. One g of compound feed sample (two blank samples to make up the calibration 
curve, one low-level IRMM sample (9.3ng/g aflatoxin B1) and one blank sample that 
had been spiked at 10ng/g) was added to 5ml 80% (v/v) methanol.   
2. The samples were filtered using Millex PVDF filters.  3ml was then removed and 
12ml of distilled water added.   
3. 10ml was then passed through the columns.   
4. The columns were washed with 10ml distilled water, and then the aflatoxin eluted 
using 1.5ml 100% (v/v) methanol and collected in a test-tube. 
5. The sample was then evaporated over nitrogen in a concentrator at 70°C and 
reconstituted in 1ml HBS.   
6. The calibration curve produced by reconstituting known amounts of aflatoxin B1 in 
blank sample instead of HBS-EP. The calibrant concentrations were 0, 0.5, 1, 2.5, 5, 
10, 2.5 and 50ng/g of aflatoxin B1. 
7. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions constitute an antibody fraction of 30% (antibody and sample are mixed 
together by the biosensor at a ratio of 30:70) and an injection time of 480 seconds.  
The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, with a 20 
second injection time. 
 
 
 
 
 
 
  
46 
2.3.3 Infant Formula Extraction Methodology 
 
2.3.3a Methanol extraction of aflatoxin B1 from infant formula 
 
1. Five 1g aliquots of infant formula were weighed out.  Two were spiked with 
aflatoxin B1. One sample was spiked with 25μl of a 400ng/ml standard, which is 
equivalent to 10ng/g.  The other was spiked with 25μl of a 40ng/ml standard, which 
is equivalent to 1ng/g.  The remaining samples were used for the calibration curve. 
2. Ten ml of 100% methanol was added to each sample, which were then vortexed and 
put on the roller for 30 minutes.   
3. The samples were then centrifuged for 10 minutes at 2000g.   
4. The supernatant was removed and filtered through a Millex PVDF filter.   
5. A volume of supernatant (7.5ml) was removed and then blown down on the 
concentrator at 70ºC over nitrogen.   
6. The samples were then reconstituted in 1ml HBS. 
7. Calibrants were made up in blank sample extract as before. The calibrant 
concentrations were 0, 0.5, 1, 2.5, 5, 10, 2.5 and 50ng/g of aflatoxin B1. 
8. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions constitute an antibody fraction of 30% (antibody and sample are mixed 
together by the biosensor at a ratio of 30:70)  and an injection time of 480 seconds.  
The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, with a 20 
second injection time. 
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2.3.3b Methanol extraction of aflatoxin B1 from infant formula with a cyclohexane 
step 
 
1. The above experiment was repeated from points 1 to 6. 
2. One ml of cyclohexane was then added, vortexed and then incubated at 37 ºC for 15 
minutes.  After centrifugation at 18000g on an Eppendorf refridgerated centrifuge for 
10 minutes, two separate phases had formed.   
3. The bottom HBS layer was carefully removed so as not to disturb the top layer, and 
the samples filtered again with the Millex filter. 
4. The blank samples were combined and used to make the calibration curve.  The 
calibrants and samples were then run on the Biacore Q biosensor, conditions as 
described in the previous assay (experiment 2.3.3a). 
 
 
2.3.3c  Extraction of aflatoxin B1 from compound feed using “Easi-extract aflatoxin” 
immunoaffinity columns from R-Biopharm Rhone 
 
1. Four 1g infant formula samples were weighed out.   
2. One sample was spiked with 25μl of a 400ng/ml standard, which is equivalent to 
10ng/g.  The other was spiked with 25μl of a 100ng/ml standard, which is equivalent 
to 2.5ng/g.  The other two blank samples were be used for the calibration curve.   
3. A volume (12.5ml) of 80% (v/v) methanol were added to the samples, vortexed for 2 
minutes, put on a roller mixer for 30 minutes and then centrifuged at 2000g for 10 
minutes.   
4. Two ml was removed and added to 16ml of PBS, pH 7.4. 
5. The columns were conditioned by passing 20ml of PBS through them.   
6. The diluted samples were then passed through the columns and then washed with 
20ml distilled water.   
7. The samples were eluted from the columns as before with 1.5ml 100% (v/v) MeOH, 
which was then blown down over nitrogen to dryness.   
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8. The samples were reconstituted in 1ml HBS.  The two blank samples were combined 
and used construct the calibration curve.  The calibrant concentrations were 0, 0.5, 1, 
2.5, 5, 10, 2.5 and 50ng/g of aflatoxin B1. 
9. The calibrants and samples were then run on the Biacore Q biosensor, with 
conditions as described in the previous assay (experiment 2.3.3a). 
 
 
2.3.3d  Acetonitrile extraction of aflatoxin B1 from infant formula 
 
1. Five 1g samples of infant formula samples were weighed out, and one was spiked at 
10ng/g aflatoxin B1.  
2. Ten ml of 100% (v/v) acetonitrile was added to each sample, vortexed vigorously, 
put on a roller mixer for 30 minutes and then centrifuged at 2000g for 10 minutes.   
3. The solvent was then filtered using Millex PVDF filters.  5ml was removed and 
blown down over nitrogen at 60C.   
4. The samples were then resuspended in 1ml HBS and vortexed vigorously.   
5. 1ml of cyclohexane was then added to each sample, vortexed and then incubated at 
37C for 15 minutes.  The samples were then centrifuged at 18,000g and the bottom 
layer removed with a syringe.   
6. The cyclohexane step was repeated for a second time.  The samples were filtered 
again using Millex PVDF filters. 
7. The blank samples were combined and used to make a calibration curve. 
8. The calibrants and samples were then run on the Biacore Q biosensor, with 
conditions as described in the previous assay (experiment 2.3.3a). 
 
2.3.3e Acetic acid precipitation of the proteins in infant formula 
 
1. Six 1g samples of infant formula were weighed out and two spiked with 1ng and 
10ng of aflatoxin B1.  The four remaining blank samples are to be used for the 
calibration curve.   
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2. Seven ml of deionised water and 1ml of 3% (v/v) acetic acid were added to the 
samples.  The samples were then made up to 10ml with more deionised water, 
vortexed and then put on a roller mixer for 30 minutes.   
3. The samples were centrifuged at 2500g for 15 minutes and 5ml was then removed.   
4. Five ml was ethyl acetate was then added, put on a roller mixer for 30 minutes and 
centrifuged again for 15 minutes at 2500g.   
5. The ethyl acetate layer was then removed and then evaporated in the concentrator at 
70C over a stream of nitrogen.   
6. The samples were then reconstituted in 1ml HBS and washed twice with 
cyclohexane, as described in 2.3.3d.  They were then filtered using the Millex PVDF 
filters. 
7. The calibrants and samples were then run on the Biacore Q biosensor, with 
conditions as described in the previous assay (experiment 2.3.3a). 
 
2.3.3f Hydrochloric acid precipitation of the proteins in infant formula 
 
1. One g aliquots of infant formula were added to 8ml 100% (v/v) methanol and 2ml 
0.1M hydrochloric acid, vortexed and then put on a roller mixer for 30 minutes. 
2. The samples were then centrifuged for 10 minutes at 2500g.  Eight ml of the 
supernatant was removed and 8ml of deionised water was added and mixed together. 
3. Four ml of hexane was added and the samples were incubated at 37˚C for 10 
minutes. 
4. The samples were centrifuged for 10 minutes at 2500g and 14ml of the bottom layer 
removed. 
5. Eight ml of chloroform was added, and the samples were vortexed and then 
centrifuged at 2500g for 10 minutes 
6. Six ml of the chloroform layer was then removed and blown down at 60˚C over a 
stream of nitrogen. 
7. The samples were then reconstituted in 1ml HBS-EP. 
8. The calibrants and samples were then run on the Biacore Q biosensor.  Conditions 
were as described in the previous assay (experiment 2.3.3a). 
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2.3.3g Extraction of aflatoxin B1 from compound feed using “Easi-extract aflatoxin” 
immunoaffinity columns from R-Biopharm Rhone using acetonitrile instead of 
methanol in the extraction step. 
 
1. Five 1g aliquots of infant formula were weighed.  Two were spiked with 
aflatoxin B1. One sample was spiked with 25μl of a 400ng/ml standard, which 
is equivalent to 10ng/g.  The other was spiked with 25μl of a 40ng/ml 
standard, which is equivalent to 1ng/g.  The remaining samples were used for 
the calibration curve. 
2. Ten ml of 100% (v/v) acetonitrile was added to each sample, which were then 
vortexed and put on the roller for 30 minutes.   
3. The samples were then centrifuged for 10 minutes at 2000g.   
4. The supernatant was removed and filtered through a Millex PVDF filter.   
5. A volume of supernatant (7.5ml) was removed and then blown down on the 
 concentrator at 70ºC over nitrogen.   
6. The samples were then reconstituted in 1ml HBS. 
7. Calibrants were made up in blank sample extract as before. The calibrant 
 concentrations were 0, 0.5, 1, 2.5, 5, 10, 2.5 and 50ng/g of aflatoxin B1. 
8. The calibrants and samples were then run on the Biacore Q biosensor.  The 
 assay conditions consisted of an antibody fraction of 30% (antibody and 
 sample are mixed together by the biosensor at a ratio of 30:70) and an 
 injection time of 480 seconds.  The regeneration solution was 10mM NaOH 
 and 20% (v/v) acetonitrile, with a 20 second injection time. 
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2.3.4  Maize  extraction methodology 
 
2.3.4a  Extraction of aflatoxin B1 from maize using the AOAC (Association of Official 
 Analytical Chemists) recommended “best food”(BF) method for corn. 
 
1. One g aliquots of maize were weighed out and one sample was spiked with aflatoxin 
B1 at a concentration of 10ng/g. 
2. Ten ml of 55% (v/v) methanol/water added.  The sample was then vortexed and put 
on the roller mixer for 30 minutes.   
3.  Five ml was removed and added to 5ml of hexane.  It was then placed on a roller 
mixer for 15 minutes and centrifuged at 2000g for 10 minutes.  
4. 2.5ml of the methanol phase was removed and 10ml of chloroform added.  The 
volume of sample was again put on the roller mixer for 30 minutes and then 
centrifuged at 2000g for 10 minutes.   
5. Finally, 5ml was removed and concentrated on the concentrator over a stream of 
nitrogen.  The sample was then reconstituted in 1ml of HBS. 
6. Calibrants were made up in blank sample extract as before. The calibrant 
concentrations were 0, 0.5, 1, 2.5, 5, 10, 2.5 and 50ng/g of aflatoxin B1. 
7. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions consisted of an antibody fraction of 30% and an injection time of 480 
seconds.  The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, 
with a 20 second injection time. 
 
2.3.4b Aflatoxin B1 extraction from maize using “Easi-extract aflatoxin” immunoaffinity 
columns from R-Biopharm Rhone  
 
1. Three maize samples of 1g were weighed out.  One was spiked with aflatoxin to a 
concentration of 10ng/g and two were blanks to make the calibration curve (two 
blanks were required to make up the volume required for the calibration curve).  
2. Five ml of 80% (v/v) methanol was added, vortexed and then put on the roller mixer 
for 30 minutes.   
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3. The sample was centrifuged at 2000g for 10 minutes, 2ml was removed and  sixteen 
ml of PBS was added.  
4. The R-Biopharm Rhone IAC were pretreated by passing 20ml of PBS through them.   
5. The samples were then passed though the columns at a speed of 1-2 drops per 
second.  The columns were then washed with 20ml deionised water to remove any 
impurities.   
6. The aflatoxins were then eluted using 2 applications of 1.5ml 100% (v/v) methanol.  
7. The samples were then evaporated to dryness on a concentrator over a stream of 
nitrogen.  Finally the samples were reconstituted in 1ml HBS. 
 
2.3.4c  Amylase treatment of maize samples before they are t through“Easi-extract 
aflatoxin” immunoaffinity columns from R-Biopharm Rhone 
 
1. Three 1g samples were weighed and to each 1ml deionised water and 0.125g of 
amylase were added.  The amylase was added to break down any starch that is 
present in the sample.  One of the samples was spiked at 20ng/g of aflatoxin B1, the 
other two were left blank as they were to be used for the calibration curve.   
2. The samples were then incubated at 37C for 30 minutes.   
3. Four ml of methanol (100% (v/v)) was then added to make a final concentration of 
80% (v/v).  The sample was then vortexed, put on the roller mixer for 30 minutes, 
centrifuged at 2000g for 10 mins and 2mls solvent removed.   
4. The 2mls solvent was then passed through the IAC as described in 2.3.4b 
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2.3.5 Extraction Methodology for Peanuts 
 
2.3.5a Extraction of aflatoxin from peanuts using methanol and immunoaffinity column 
clean-up 
 
1. One g of blank sample of ground peanuts, or sample that had been spiked at 5ng/g 
was vortexed with 10ml 80% (v/v) methanol/water.   
2. The samples were then placed on a roller mixer for 30mins with the spiked samples 
protected from light.  The samples were then centrifuged at 1600g on a bench 
centrifuge for 10mins.   
3. Two ml of the sample was removed and 16ml of PBS, pH 7.4, was added.   
4. The columns were first conditioned using 20ml PBS, pH 7.4.   
5. The samples were then passed through the column, and then the columns were 
washed with 20ml ddH2O.    
6. The samples were eluted by passing and then collecting 2 volumes of 1.5ml 100% 
(v/v) methanol.   
7. The eluted fraction was blown down in a concentrator at 70°C over a stream of 
nitrogen.   
8. The samples were then reconstituted by adding 1ml HBS and vortexing for 2mins.  
The blank samples that were used to make the calibration curve were all filtered 
using Millex 0.2μm PVDF filters.   
9. One blank sample and one spiked sample were both filtered using PDVF filters (as in 
8).  The other blank and spiked sample were left unfiltered. 
10. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions consisted of an antibody fraction of 30% and an injection time of 480 
seconds.  The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, 
with a 20 second injection time. 
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2.3.5b Acetonitrile extraction of aflatoxin B1 from peanuts followed by an 
immunoaffinity column cleanup 
 
1. One g of blank sample or sample that had been spiked at 5ng/g was vortexed with 
10ml 60% (v/v) methanol/water.   
2. The samples were then mixed on a roller for 30mins with the spiked samples 
protected from light.  The samples were then centrifuged at 1600g for 10mins.   
3. Two ml of the sample was removed and 48ml of PBS, pH 7.4, was added.   
4. The columns were first conditioned using 20ml PBS, pH 7.4.   
5. The samples were then passed through the column, and then the columns were 
washed with 20ml ddH2O.    
6. The samples are eluted by passing and then collecting 2 aliquots of 1.5ml 100% (v/v) 
methanol.   
7. The methanol was blown down in a concentrator at 70°C over a stream of nitrogen.   
8. The samples were then reconstituted by adding 1ml HBS and vortexing for 2mins.  
The blank samples that were used to make the calibration curve were all filtered 
using Millex 0.2μm PVDF filters.   
9. One blank sample and one spiked sample were filtered using the PDVF filters.  The 
other blank and spiked sample were left unfiltered. 
10. The calibrants and samples were then run on the Biacore Q biosensor.  The assay 
conditions consisted of an antibody fraction of 30% and an injection time of 480 
seconds.  The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, 
with a 20 second injection time. 
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2.3.5c Treatment of peanuts with Polyvinylpyrrolidone (PVP) to remove tannins 
present in the skins of peanuts 
 
Peanut samples caused a large amount of non-specific binding.  It was thought that 
the non-specific binding may have been caused by the tannins present in the peanut 
skins.  Polyvinylpyrrolidone (PVP) can be used to remove tannins. 
 
1. The samples were treated as follows:- 
 
 Sample 1.   1g Julian Graves peanuts and 4ml PVP were vortexed for 30 secs, 
placed on a roller mixer for 3mins and 6ml of water added. 
 Sample 2. 1g Julian Graves peanuts and 4ml PVP was vortexed for 30 secs, placed on 
a roller mixer for 3mins and then 6ml acetonitrile added (to bring to 60% (v/v) 
acetonitrile/water) 
 Sample 3. 1g Julian Graves peanuts and 4ml 60% acetonitrile were vortexed for 30 
secs, put on a roller mixer for 3mins and then 6ml 60% (v/v) acetonitrile/water 
added. 
 Sample 4. 1g FAPAS peanuts and 4ml 60% (v/v) acetonitrile/water was vortexed for 
30 secs, put on a roller mixer for 3mins and then 6ml 60% acetonitrile added. 
 
2. All the samples were put on a roller mixer for 30mins and then centrifuged.   
3. Two ml from each sample was removed and added to 48ml PBS.   
4. The samples were passed through the IAC, as described in the previous experiment 
(2.3.5b). 
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2.3.5d Optimised assay for the extraction of aflatoxin from peanuts 
 
1. Fifty g quantities of peanuts were weighed out and 500ml of 80% (v/v) 
methanol/water added. 
2. Samples were shaken vigorously and put on a roller mixer for 30 minutes. 
3. The samples were then centrifuged at 2000g on a bench centrifuge for 10 minutes, 
2ml removed and mixed with 14ml PBS, pH 7.4. 
4. The “Easi-extract aflatoxin” columns were first conditioned using 20ml PBS, pH 7.4.   
5. The samples were then passed through the column, and then the columns were 
washed with 20ml ddH2O.    
6. The samples are eluted by passing and then collecting 2 aliquots of 1.5ml 100% (v/v) 
methanol.   
7. The methanol was blown down in a concentrator at 70°C over a stream of nitrogen.   
8. The samples were then reconstituted by adding 1ml HBS and vortexing for 2mins.   
9. The calibrants for the calibration curve were made out of blank sample as follows:- 
 
Amount and concentration of aflatoxin B1 added to 
blank sample 
Calibrant 
concentration 
(ng/g blank 
sample) 
40µl 125ng/ml aflatoxin B1 + 960µl  blank sample 25 
40µl 50ng/ml aflatoxin B1 + 960µl blank sample 10 
40µl 25ng/ml aflatoxin B1 + 960µl blank sample 5 
40µl 12.5ng/ml aflatoxin B1 + 960µl blank sample 2.5 
40µl 5ng/ml aflatoxin B1 + 960µl blank sample 
 
1 
40µl 2.5ng/ml aflatoxin B1 + 960µl blank sample 0.5 
40µl HBS + 960µl blank sample 0 
 
10. The calibrants and samples were then filtered using Whatman anatop filters. 
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11. The calibrants and samples were then run on the Biacore Q biosensor.  The optimised 
assay conditions consisted of an antibody fraction of 20% and an injection time of 
600seconds.  The regeneration solution was 10mM NaOH and 20% (v/v) acetonitrile, 
with a 20 second injection time. 
 
 
2.3.6 General Methodology 
 
2.3.6a  Decontamination of consumables and glassware that have come into contact 
with aflatoxin 
 
Aflatoxin B1 is a toxic substance.  Therefore, several precautions had to be carried 
out when handling it.  Protective clothing and gloves were worn at all times.  
Standards were made up in a fume cupboard whilst wearing a mask.  Aflatoxin B1 is 
sensitive to light and therefore was stored in vials that were protected form sunlight. 
 
1. All materials and reagents that have been contaminated with aflatoxin were soaked in 
a solution of 5% (v/v) sodium hypochlorite for at least 30 minutes. 
2. The 5% (v/v) sodium hypochlorite is then removed, and the materials are then 
soaked in 5% (v/v) acetone for another 30 minutes. 
3. Glassware was then washed as per normal practice.   
4. The consumable materials (i.e. pipette tips, eppendorfs, centrifuge tubes) were 
disposed of with normal lab wast
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3.1  Format of aflatoxin B1 assay using a Biacore Q biosensor 
 
Aflatoxin B1 is a small molecule, with a molecular weight of 312 Da, which when binding 
to the chip surface would not create a large enough change in resonance to facilitate easy 
detection in complex matrices.  The aflatoxin B1 assay, therefore, was formatted as an 
inhibition assay, where the amount of antibody binding to the surface is measured. 
 
In an inhibition assay the chip surface is immobilised with the analyte or a derivative of the 
analyte.  In this assay a derivative of aflatoxin B1 is immobilised to the chip surface.  A 
fixed amount of the recombinant antibody is mixed with the sample prior to injection.   
Aflatoxin B1 present in the sample will bind to the antibody and therefore inhibit it from 
binding to the surface of the sensor chip. The higher the concentration of the analyte in the 
sample, the more antibodies will bind to it, causing a higher level of inhibition.  This 
produces a lower response of the biosensor.  A calibration curve is generated using the 
responses produced from known standards.  The amount of aflatoxin B1 in a sample can 
then be quantified in reference to this curve (Van der Gaag et al., 2003). 
. 
   
3.2  Development of a sensor chip for the aflatoxin B1 assay 
 
Zhanna Samaonova was a previous employee of Xenosense Ltd, and had previously carried 
out a study to determine the most efficient way of immobilising aflatoxin B1 onto the chip 
surface.  Direct immobilisation of aflatoxin B1 was compared to the immobilisation of 
several aflatoxin B1 derivatives and immobilisation methods.  These included aflatoxin B1-
hydrazone (2 hour and overnight immobilisations), aflatoxin B1-oxime (immobilised with 
hydrazine, ethylendiamine, jeffamine or 1,6-hexanediamine), an aflatoxin B1-BSA or an 
aflatoxin B1 amine derivative (both amine coupling immobilisation) and aflatoxin B1-
oxime-ethylenediamine (2 hour or overnight amine coupling immobilisation).  The 
derivative that showed optimal immobilisation was aflatoxin B1-oxime-ethylenediamine. 
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Aflatoxin B1-oxime-ethylenediamine was made producing a yield of 22.8mg (Figure 3.2).  
This yield is poor.  Another disadvantage of the method is that the purity of the amine is 
unknown. 
 
Figure 3.1  Diagram showing the reactions and chemical structures of the products and 
intermediates in the formation of aflatoxin B1-oxime-ethylenediamine.  Aflatoxin B1 is 
dissolved in pyridine and carboxymethyloxime hydrochloride added.  The pyridine is 
evaporated under a stream of nitrogen and gentle heating producing intermediate I.  
Next, 32mg N,N'-dicyclohexyl-carbodiimide (DCC) and 20mg N-hydroxysuccinimide 
(NHS) is added to produce intermediate II.  To produce aflatoxin B1-oxime-
ethylenediamine ethylenediamine is added to intermediate II. 
 
 
 
 
3.3  Testing the efficacy of the surface of the aflatoxin B1 assay sensor chip 
Aflatoxin B1 
Intermediate I Intermediate II 
Aflatoxin B1-oxime-
ethylenediamine 
II   DCC 
NHS 
carboxymethoxylamine 
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Aflatoxin B1-oxime-ethylenediamine was immobilised onto the chip surface.  To determine 
the efficiency of immobilisation, the maximum binding capacity, Rmax, was calculated. This 
was achieved by first injecting a regeneration solution over the surface, which is strong 
enough to remove all unbound molecules, but will not destroy the binding of the derivative 
with the surface of the chip.  In the case of the aflatoxin assay, the most efficient 
regeneration solution was found to be 10mM NaOH/20% (v/v) acetonitrile. An excess of 
antibody was then passed over the chip surface over a long injection time of 20 minutes 
with a flow rate of 5μl/min.  
 
If the immobilisation was successful, the resulting sensorgram should show binding to the 
surface equivalent to several thousand RU.  This is shown in figure 2.2.  As a control an 
unrelated antibody was also passed across the surface to confirm that the binding was 
specific (sensorgram not shown). 
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3.4  Evaluation of the feasibility of the aflatoxin B1 assay 
 
Initially the feasibility of the assay had to be proved by generating a standard curve in 
buffer.  The buffer used with Biacore was HBS-EP.  The standards for the calibration curve 
were made up from a stock solution of 1mg aflatoxin B1 (Fermentek, Israel) in 1ml 100% 
(v/v) methanol, and the antibody was a mouse monoclonal anti-aflatoxin B1 antibody 
produced in mouse from Sigma. 
 
A calibration curve was produced for aflatoxin B1 in a buffer system.  This would indicate 
that an assay using food matrices may be feasible. 
 
Figure 3.3 Aflatoxin B1 calibration curve in HBS buffer 
A calibration curve for Aflatoxin B1 was produced in buffer using the calibration points 
0ng/ml (as shown by 0.001ng/ml in the table as it is not possible to give a value of 
0ng/ml), 0.5ng/ml, 1.0ng/ml, 2.5ng/ml, 5ng/ml and 10ng/ml of Aflatoxin B1.  A 
calibration curve was produced, demonstrating that the assay works in a buffer system. 
The table above shows the cycle number, the concentration of aflatoxin in ng/ml that was 
passed over the surface in that cycle and the respose in arbitrary response units (RU).  It 
also shows whether the data quality was good and shows the calculated concentration of 
the sample when the response is read off the calibration curve.  The coefficient of 
variation is also calculated between two samples of the same concentration.  However, 
more than two samples would be needed for a more accurate measure of the CV. 
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3.5  Evaluation of the anti-aflatoxin B1 antibodies for use in an assay using a 
Biacore Q biosensor 
 
Antibodies were supplied to us by Professor Richard O‟Kennedy, School of Biotechnology, 
Dublin City University as part of the FUSION programme. These antibodies were produced 
using phage display technologies.  They were a  monomeric (400), a dimeric (500) and 2 
Fab fragments (D11 and G6).  The four recombinant antibodies were compared to a 
commercial monoclonal anti-aflatoxin B1 antibody.    
 
A series of curves were set up using all four antibodies added in various percentage 
fractions, and comparing different injection times, to determine the most sensitive antibody 
and assay conditions.  The antibody to sample ratio for each antibody was either 30/70 (v/v) 
or 50/50(v/v) and the injection times were 120 secs, 240 secs and 480 secs.  The standards 
used in the curve were 0, 0.5, 1, 2.5, 5, 10, 25 and 50ng/g of aflatoxin B1. 
 
To determine which antibody is the most sensitive, and what concentration and contact time 
were optimal, the midpoint of the curve was calculated.  This was done by halving the 
difference between the highest and the lowest responses on the curve and reading off the 
curve to give a concentration of aflatoxin.  The lower the midpoint, the more sensitive the 
curve is.  Another important factor is that the range of the curve is sufficient.  It should 
have a range of 400-600RU. 
 
The results are shown in Table 3.1.  The Fab G6 was found to be the most sensitive for use 
with the biosensor, using an antibody fraction of 30% (antibody and sample are mixed 
together by the biosensor at a ratio of 30:70) and an injection time of 480 secs.  It also had a 
good range at these parameters from 32.9 to 451.3RU. 
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Table 3.1  Table of results showing the midpoint values for antibodies G6, D11 and 
scFv500 each with a range of antibody fractions and contact times.  To evaluate which 
antibody is the most sensitive and at what conditions a range of calibration curves were 
carried out in buffer for the anti-aflatoxin antibodies G6, D11 and scFv500.  Two 
different antibody fractions (30 and 50% antibody) and contact times of 120, 240 and 480 
secs were compared.  The concentrations of aflatoxin B1 at the midpoints of each curve 
were compared.  The lower the concentration, the more sensitive the antibody is.  The 
range of the curve is also a factor when choosing an antibody.  It should have a range of 
400-600RU between 50ng/g and 0ng/g.  The results show that the Fab antibody G6, with 
and antibody fraction of 30% and an injection time of 480secs was sufficiently sensitive 
and had a sufficiently wide analytical range, as this produced the lowest midpoint but 
with a range of over 400RU. 
 
ANTIBODY Ab 
fraction 
(%) 
Contact 
time 
(secs) 
Response at 
an aflatoxin 
B1 
concentration 
of  50ng/g 
Response at 
an aflatoxin 
B1 
concentration 
of  0ng/g 
Concentration 
of aflatoxin B1 
at the 
midpoint of 
the curve 
(ng/g) 
G6 50 120 47.3 494.2 4.8 
  30 120 21.1 307.6 2.0 
  50 240 65.7 491.2 5.1 
  30 240 29.7 379.8 2.5 
  50 480 87.4 513.7 5.9 
  30 480 32.9 451.3 3.1 
 D11 50 120 16.4 245.6 2.0 
  30 120 4.5 120.1 1.4 
  50 240 16.7 193.4 3.0 
  30 240 7.1 120.4 1.7 
  50 480 22.4 186.2 3.6 
  30 480 7.7 149.6 1.9 
scFv500 50 240 65.6 369.6 5.9 
  30 240 28.2 221.8 3.3 
  50 480 58.8 488.2 5.8 
  30 480 70.9 393.8 3.2 
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4.1  Introduction 
 
The range of commodities that are affected by aflatoxins is very broad as contamination can 
occur at any time from pre-harvest, from storage and during transportation (Kabak et al., 
2006).  Cereals such as maize, rice and wheat, and nuts (e.g. peanuts, brazil nuts and 
pistachios) can be affected at any stage of the farming cycle, whilst spices and dried fruit 
are most likely to become contaminated when stored.  Aflatoxins can withstand high 
temperatures and, therefore, can also be present in processed foods.  Recently, in 
September 2006, snacks containing rice flour contaminated with aflatoxins were withdrawn 
from several large retailers in the UK (RASFF, Rapid Alert System for Food and Feed).  
Another product that was associated with aflatoxin contamination is peanut butter when 
made from contaminated peanuts.  Milk and milk products may also have aflatoxin 
contamination due to metabolism of ingested aflatoxins by dairy cows. 
 
Aflatoxins can be extracted from food matrices using a number of different solvents, 
including methanol, acetonitrile, chloroform, acetone and DMSO.  However, pure solvents 
are not as efficient as solvents that have been diluted with water.  The ratios of solvent to 
water are critical, as are the solvent to matrix ratio (Whitaker et al., 1986).  Also, some 
solvents work best for different matrices.  For example, R-Biopharm Rhone recommend an 
80% (v/v) methanol extraction for nuts, figs, maize and cereals, whereas for spices, 
compound feed and herbs a 60% (v/v) acetonitrile solution is advised. 
 
Solvent extraction, however, can be problematic because other impurities from the matrix 
are often extracted along with the aflatoxin.  These impurities may also bind non-
specifically to the surface of the sensor chip.  Non-specific binding (NSB) can, therefore, 
lead to false results.  A popular way of reducing NSB is the use of clean-up columns.  SPE 
(solid phase extraction) columns or immunoaffinty columns (IAC) are frequently used to 
isolate an analyte from a matrix and also to concentrate the samples (Stroka et al., 2000;  
Senyuva et al., 2005; Ip et al., 2006; Turner et al., 2009).   
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SPE columns contain a matrix, which is known as the solid phase.  The extraction process 
works on the premise that the analyte of interest has a far greater affinity for the matrix than 
the impurities in a sample.  Once the sample has been extracted, using a suitable solvent 
and passed through the SPE column, the analyte has a stronger affinity to the solid phase 
than the rest of the matrix.  Therefore, the impurities are washed away, and the purified 
analyte can be eluted from the column.  A variety of different stationary phases can be 
used, depending on the charge of the analyte of interest.  Most are based on a bonded silica 
material derivatised with a functional group to confer a positive or negative charge (Turner 
et al., 2009).  The main disadvantage of SPE is that the matrix may contain impurities that 
have the same charge as the analyte.  These too will be adsorbed on to the solid phase, and 
so the analyte may not be pure. 
           
In contrast, IACs are also based on a column filled with a matrix.  This matrix, however, 
contains antibodies that have affinity specifically for the analyte of interest.  Therefore 
when a sample is passed through the column only the analyte binds to the surface, washing 
away all other impurities.  Therefore, the advantage of this system is that the eluate 
contains a pure solution of the analyte.  A disadvantage is that these columns can be very 
expensive (Castegnaro et al., 2006). 
 
The purpose of this project was to develop a diagnostic kit to test for aflatoxins in a range 
of foodstuffs that will be launched as a product alongside the other food testing kits 
developed and manufactured by Xenosense Ltd.  The matrices chosen are dependant on a 
number of factors.  For example, what is the unique selling factor of this test?  What tests 
are there already available on the market?  At the beginning our tests will be targeted at 
existing customers, which include Nestle, Kraft and Analyscen.  Therefore, it is very 
important that the commodities that are within the capabilities of testing by the kit coincide 
with the interests of potential customers. 
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4.2 Compound Feed (IRMM Reference Material) 
 
4.2.1.Introduction 
 
The first matrix to be investigated was a reference material.  The reference material was 
compound feed, which was commercially available from Sigma Aldridge.  Spiked samples 
can sometimes behave differently than real samples, so it was decided to try to optimise the 
assay using real samples first.  The reference material was purchased from the Institute for 
Reference Materials and Measurements (IRMM). Two samples were bought that had been 
certified to contain 0 ng/g (blank) and 9.3 ng/g aflatoxin B1. 
 
4.2.2 Results 
 
The most common extraction solvent for aflatoxin B1 is methanol.  Therefore a simple 
methanol extraction was carried out using compound feed reference material that contained 
9.3 ng/g aflatoxin B1.  The sample was run against a standard curve made from aflatoxin B1 
in HBS-EP buffer.  The sample, however, gave reading that were “off-scale”, showing  
major interference effects from the matrix. 
 
To remove the matrix effects from the sample the use of solid phase extraction (SPE) 
columns and immunoaffinity columns (IAC) was investigated. 
 
“Mycosep” SPE columns, purchased from Romer Laboratories, were evaluated initially as 
they were considerably less expensive than the immunoaffinity columns.  The first 
extraction was read off a standard curve that had been created using HBS-EP buffer.  The 
results showed apparent recoveries of about 1000%.  This would suggest that, again, there 
was interference from the sample matrix.  The experiment was then repeated.  This time, 
however, the standard curve was constructed using blank sample extract instead of buffer.  
The reasoning for this is that the sample and the calibration curve are directly comparable.  
However, the calibration points obtained were erratic, and a calibration curve was not 
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generated, so that it was impossible to determine the concentration of aflatoxin B1 in the 
sample from the constructed standard curve.  This was, again, due to matrix interference. 
 
In an attempt to remove matrix interference immunoaffinity columns were tested.  There 
are many IAC specific to aflatoxins available.  “Easi-extract aflatoxin” IAC are mentioned 
frequently in papers and other published documents and were, therefore, first to be 
evaluated 
 
The calibration curve was made using a blank sample extract.  On this occasion the curve 
showed little matrix interference.  The concentration of the sample when it was read off the 
curve was 9.3 ng/g.  The compound feed was certified as containing aflatoxin B1 at a 
concentration of 9.3 ng/g.  This gives a recovery of 100.5%.  The experiment was then 
repeated to prove that the results could be replicated.  The recovery from the certified 
compound feed sample was 9.08 ng/g, which is 98%.  These results are shown in Figure 
4.1.  This shows that the “easi-extract aflatoxin” IAC are very effective in sample clean-up.   
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Figure 4.1  Aflatoxin B1 in compound feed reference material assay using “Easi-extract 
aflatoxin” immunoaffinity columns commercially available from R-Biopharm Rhone 
The table above shows the cycle number, the concentration of aflatoxin in ng/ml that was 
passed over the surface in that cycle and the respose in arbitrary response units (RU).  It 
also indicates whether the data quality was good and shows the calculated concentration 
of the sample when the response is read off the calibration curve.  The coefficient of 
variation is also calculated between two samples of the same concentration. 
Aflatoxin B1 was extracted from compound feed using“Easi-extract aflatoxin” 
immunoaffinity columns.  The feed had been certified to contain aflatoxin B1 at a 
concentration of 9.3 ng/g. Using a calibration curve that had been created using blank 
extracted sample, the calculated recovery of aflatoxin B1 from the sample was given as 
9.08 ng/g, which is 98%.  The coefficient of variation (% CV) was 4.4. 
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One disadvantage of the columns is that they are very expensive, especially since they are 
recommended for single use only.  To determine how many times a column could actually 
be used the experiment was repeated, but the column used for the sample was re-used nine 
times.  The sample used was the compound feed  certified as containing aflatoxin B1 at a 
concentration of 9.3 ng/g. 
 
The results  (Table 4.1) show that the recovery dropped to 88% after one use and after 6 
times the recovery was 25%.  This proves that the columns are not re-usable. 
 
Table 4.1 Table showing the re-usablity of the “Easi-extract aflatoxin” immunoaffinity 
columns.  “Easi-extract aflatoxin” IAC were re-used several times.  The eluate was 
collected each time and the recoveries were calculated using a calibration curve that had 
been constructed using a blank extracted sample.  The recoveries dropped significantly 
each time the columns were re-used, thus proving the columns cannot be used more than 
once. 
Sample name Number of times 
the column used 
% Recovery 
A 1 88 
B 2 73 
C 3 78 
D 4 67 
E 5 sample lost 
F 6 25 
G 7 32 
H 8 12 
I 9 26 
 
 
There are many other immunoaffinity columns for aflatoxin B1 clean-up on the market.  
Another column that has been used in a variety of papers is the “Aflatest” IAC from Vicam.  
These columns were found to be considerably cheaper than the IAC from R-Biopharm 
Rhone.  Therefore, these columns were used to compare their effectiveness in the 
compound feed assay. 
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The experiment was repeated using “Aflatest” IAC.  IRMM compound feed (certified to 
contain 9.3 ng/g aflatoxin B1) and a spiked blank sample (containing 10ng/g aflatoxin B1) 
were extracted and the recoveries calculated using a calibration curve made using blank 
extracted sample.  The columns seemed to remove most of the matrix effect because the 
calibration curve produced showed little interference.  The recoveries of the samples, 
however, were lower than expected.  The real sample had a recovery of 4.68 ng/g (50.3%) 
and the spiked sample had a recovery of 3.57 ng/g (35.7%).  This would suggest that some 
of the aflatoxin B1 is being lost through the “Aflatest” IAC, and that they are not as 
effective as “Easi-extract aflatoxin” IAC.  This is illustrated in Figure 4.2. 
 
To further test the efficacy of the columns the experiment was repeated in a buffer system.  
This experiment removes any interference that might have been caused by the matrix.  The 
calibration curve was constructed using HBS-EP and the “sample” was HBS-EP buffer 
spiked with 10ng/ml of aflatoxin B1.  The recovery of the aflatoxin B1 in buffer was 
approximately 67%, which is considerably lower than the recoveries using the “Easi-extract 
aflatoxin” IAC. 
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Figure 4.2 Aflatoxin B1 in compound feed reference material assay using “Aflatest” 
immunoaffinity columns commercially available from Vicam. 
Aflatoxin B1 was extracted from compound feed using“Easi-extract aflatoxin” 
immunoaffinity columns.  Samples used were IRMM compound feed (certified to contain 
9.3 ng/g aflatoxin B1) and a spiked blank sample (containing 10ng/g aflatoxin B1).  The 
real sample had a recovery of 4.68 ng/g (50.3%) and the spiked sample had a recovery of 
3.57 ng/g (35.7%). 
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4.3 Infant Formula 
 
4.3.1 Introduction 
 
The feasibility of the aflatoxin assay had been proven with matrix using the compound feed 
reference material.  The first matrix chosen to investigate was infant formula.  Infant 
formula has regulatory limits set by the EU at 0.05ng/g.  These limits are the lowest set by 
the EU for aflatoxin B1 in any food.  The reason why the limits are so low is that the food is 
designed for consumption by babies who would be extremely vulnerable towards aflatoxin 
toxicity.  In addition, there are currently no rapid tests available in the market able to detect 
such low concentrations.  This would be a unique selling point for the kit and the reason 
why infant formula was chosen as the first matrix to examine in detail. 
 
4.3.2 Results 
 
To minimise cost for budgetary and commercial feasibility it was decided to first 
investigate sample preparations that did not use expensive IACs.  The simplest extraction 
procedure involved using methanol.  A simple methanol extraction was carried out using 
infant formula that had been spiked with aflatoxin B1.  The calibration curve was 
constructed using calibrant that had been made from blank infant formula that had gone 
through the same methanol extraction as the spiked sample. 
 
Unfortunately, when the calibrants were analysed there was too much interference from the 
matrix and a calibration curve could not be generated.  Infant formula contains a high 
perventage of fat, which could bind to the chip surface.  The experiment was, therefore, 
repeated except that an additional cyclohexane step was introduced.  Cyclohexane is used 
to remove fat from the sample.  Results are shown in Figure 4.3. 
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Figure 4.3 Aflatoxin B1 extraction from infant formula using a simple methanol 
extraction and including a cyclohexane step. 
Infant formula was spiked with aflatoxin B1 to a concentration of 10 ng/g.  This spiked 
and blank samples (that were later used to construct the calibration curve) underwent a 
simple 100% methanol extraction followed by treatment with cyclohexane to remove 
matrix effect caused by fat.  A calibration curve was generated, but the recovery was only 
10% of the spiked sample. 
 
 
The matix effect seemed to be removed from the infant formula by the cyclohexane step 
and a calibration curve was generated.  However, the recovery for the spiked sample was 
very low.  The 10 ng/g spiked sample only had a recovery of 10%.   There are several 
possible reasons as to why aflatoxin B1 was lost in the extraction.  For example, the 
temperature for the concentration step was too high and was somehow damaging the 
aflatoxin B1, or that the reconstitution step in HBS-EP was not thorough enough.  The 
experiment was repeated, but the vortexing steps for extraction and reconstitution were 
more vigorous, lasting 2 minutes.  Also, the temperature of the concentrator was reduced 
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from 70 to 60˚C.  The recoveries were only slightly improved, increasing from 10% to 
16%.  Therefore, other extraction methods had to be investigated. 
 
Acetonitrile is another solvent that is recommended for aflatoxin B1 extraction.  The 
methanol extraction method, which included the cyclohexane washes, was repeated using 
acetonitrile instead of methanol.  There was a slight improvement in the recoveries (the 10 
ng/g spike had a recovery of 26%), but they were still very low.  The experiment was 
repeated without the cyclohexane washes to determine whether the aflatoxin B1 was lost 
along with the fat in the sample.  The calibrants, however, made from “blank-extracted” 
sample had too much matrix interference and a satisfactory calibration curve could not be 
generated. 
 
Infant formula also contains a high percentage of protein.  It was possible that the aflatoxin 
was binding to the proteins in the matrix and was then being removed.  Therefore, several 
methods were performed to precipitate out the proteins.  The first method used acetic acid.  
This experiment was repeated using either ethyl acetate or chloroform as the extraction 
solvents.  Again, the recoveries were low.  Both solvents had recoveries of 13% for samples 
spiked at 10ng/g.    Hydrochloric acid was then used to precipitate the proteins instead of 
acetic acid.  A sample spiked with 4 ng/g aflatoxin B1 was added to a mixture of 100% 
methanol and 0.1M hydrochloric acid.  After the protein precipitation, a hexane wash was 
completed to remove fat from the sample.  The aflatoxin B1 was then extracted using 
chloroform.  However, the recovery was only 15%. 
 
Excellent results had previously been achieved for aflatoxin B1 extraction from compound 
feed using “Easi-extract aflatoxin” IAC from R-Biopharm Rhone.    The use of these 
columns had been avoided because they were so expensive, but, because of the failure of 
simple solvent extraction to yield good recoveries, the columns were assessed for use in the 
infant formula assay. 
 
Two blank infant formula samples were spiked with aflatoxin B1, one at 2.5 ng/g and the 
other at 10ng/g.  An 80% methanol extraction was first carried out and then the samples 
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were put through the “Easi-extract aflatoxin” IAC.  A calibration curve was constructed 
using blank samples that had also been put through the IAC.  The results showed, however, 
that again, the recoveries were low being 24% for the 2.5ng/g spike and only 13% for the 
10 ng/g spiked sample. 
 
R-Biopharm Rhone recommends both methanol and acetonitrile as solvents for aflatoxin B1 
extraction.  The experiment was repeated using 100% acetonitrile for the extraction solvent 
instead of 80% methanol.  The IAC were conditioned, samples added and washed as 
before.  This time, however, the 10 ng/g spike had an apparent recovery of 137%.  It is 
impossible to have recoveries over 100%, so the results are too high.  However, of major 
concern, was the sensitivity of the curve.  The regulation limits for aflatoxin B1 in infant 
formula are 0.05 ng/g.  Therefore, this assay must be sensitive enough to detect to these 
levels.  In order to increase the sensitivity of the assay the experiment was repeated using a 
smaller extraction volume.  R-Biopharm Rhone recommend an extraction volume of 10ml.  
In order to increase the sensitivity of the assay, however, 5ml of 100% acetonitrile were 
used.  Two spiked samples were used in this assay (1 ng/g and 5 ng/g).  Although the 
recoveries for the 5ng/g spike were promising (the recoveries were an average of 78%), 
those for the 1ng/g were erratic.  One of the recoveries was 100.4% but the other was 
384%.  The reason for this is that the sensitivity of the curve at this concentration is very 
poor.  This is not acceptable for an infant formula assay as it has to be able to detect levels 
down to 0.05 ng/g.  It seemed very unlikely, therefore, that even with the use of IAC, that a 
calibration curve of this sensitivity can be achieved. The outcomes of the various 
approaches are summarized in Table 4.2.  Hence, it was decided to concentrate on other 
potential matrices of commercial relevance that might be more feasible for assay 
development. 
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Table 4.2 Results for experiments extracting aflatoxin B1 from infant formula 
Aflatoxin B1 was extracted from infant formula using a variety of extraction solvents and immunoaffinity columns were 
evaluated.  Fat and protein removal techniques were also assessed. 
 
 
Title of Experiment 
Calibration 
curve 
produced? 
Level at which 
aflatoxin B1was 
spiked (ng/g) 
% Recovery  
Problem with assay 
Methanol extraction of aflatoxin B1 from infant formula No 10 n/a No calibration curve 
produced 
Methanol extraction of aflatoxin B1 from infant formula with a 
cyclohexane step 
Yes 10 10 Recovery very poor 
Methanol extraction of aflatoxin B1 from infant formula with a 
cyclohexane step (more stringent washing, lower evaporation 
temperature) 
Yes 10 16 Recovery very poor 
Acetonitrile extraction of aflatoxin B1 from infant formula Yes 10 26 Recovery very poor 
Acetonitrile extraction of aflatoxin B1 from infant formula 
without a cyclohexane step 
No 10 n/a No calibration curve 
produced 
Acetic acid precipitation of the proteins in infant formula using 
ethyl acetate as extraction solvent 
Yes 10 13 Recovery very poor 
Acetic acid precipitation of the proteins in infant formula using 
chloroform as extraction solvent 
Yes 10 13 Recovery very poor 
Hydrochloric acid precipitation of the proteins in infant formula Yes 4 15 Recovery very poor 
 
Extraction of aflatoxin B1 from compound feed using “Easi-
extract aflatoxin” immunoaffinity columns from R-Biopharm 
Rhone 
Yes 2.5 24  
Recoveries very poor 
10 13 
Extraction of aflatoxin B1 from compound feed using “Easi-
extract aflatoxin” immunoaffinity columns from R-Biopharm 
Rhone using acetonitrile instead of methanol in the extraction 
step 
Yes 10 137% Recoveries very high and 
calibration curve not 
sufficiently sensitive 
Extraction of aflatoxin B1 from compound feed using “Easi-
extract aflatoxin” immunoaffinity columns from R-Biopharm 
Rhone using acetonitrile instead of methanol in the extraction 
step (more sensitive assay) 
Yes 1 
 
Too erratic Calibration curve not 
sufficiently sensitive 
5 78 
 
 4.4 Maize 
 
4.4.1 Introduction 
 
The FAO has estimated that 25% of grains and cereals worldwide have been contaminated 
by mycotoxins.  This includes aflatoxins.  Cereals and grains are both major constituents of 
the human food chain and the main food-stuff fed to livestock.  Therefore, cereals 
contaminated with aflatoxins can have a huge adverse impact on animal husbandry, as they 
have been shown to reduce immunity, decrease fertility, decrease weight gain, cause a 
reduction in milk production and, when contamination is high enough, mortality.  It is of 
great significance for dairy cows, where aflatoxin is metabolised and then excreted via the 
milk in the form of aflatoxin M1. Thus, control of aflatoxin contamination of cereals is 
essential for production economics, animal health, food safety and product quality. 
 
A cereal that is at high risk of aflatoxin contamination is maize.  Maize is the major cereal 
for both human and livestock consumption in many African and South-East Asian diets, 
and in North America it is the staple food for livestock.  Therefore, control of aflatoxin 
levels in corn is crucial and it was for this reason that it was chosen as the next sample 
matrix.  In addition,  it was thought that sample preparation would be easier than that for 
infant formula as it is not as complex a matrix.  The lowest regulatory limits for the 
detection of aflatoxin B1 in corn was set by the EU and is 2ppb (Commission Regulation 
(EC) No 2174/2003 of 12 December 2003). 
 
4.4.2 Results 
 
The AOAC recommends the “Best Food” (BF) method for the extraction of aflatoxins from 
corn.  The method involves a 55% (v/v) methanol/water extraction, followed by a hexane 
step and then a final chloroform extraction.  The calibration curve was generated using 
extracted blank sample.  A calibration curve was formed.  However, the background was 
very high caused by interference from the matrix and the sample reading was of the scale. 
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“Easi-extract aflatoxin” columns had previously proved successful with sample preparation 
of compound feed.  Therefore, the columns were used in the maize assay to remove matrix 
effects.  R-Biopharm Rhone recommended that the extraction buffer for maize should be 
80% methanol.  However, it was found that the background was quite high.  Nonetheless, a 
calibration curve was generated.  The recovery from a sample spiked at 10ng/g was only 
60%.  The reason for this may have been the high background recorded due to matrix 
effects. 
 
The IAC are supposed to remove all matrix interference from the maize samples.  However, 
the high background of the calibration curve shows that there is still some matrix effect.  
One attempt to remove matrix interference was to carry out a “Best Food” (BF) method 
extraction followed by the use of the IAC.  Unfortunately, this did not fully remove the 
background and the recoveries of the sample spiked at 10ng/g dropped to 32%.   
 
Maize is mostly composed of starch.  It was thought that the starch could be binding non-
specifically to the chip surface causing the high background.  The composition of maize is 
shown in Table 4.3. 
 
Table 4.3 Composition of Maize (USDA National Nutrient Database for Standard 
Reference) 
 
Component of maize % composition 
Starch 62 
Corn Oil 4 
Protein 8 
Fibre 11 
Water 15 
 
Starch content was reduced by treatment with the enzyme amylase, which seemed to 
considerably improve the assay as shown by the results in Figure 4.4 and the accompaning 
tables.  The background was reduced from 1760RU to 1280RU at the 0ng/g calibrant point 
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of the curve.  The range of the calibration curve had also improved with a drop of 300RU 
between 0 and 50ng/g.  The larger the drop in the calibration curve, i.e. the greater the 
difference in RU, the more sensitive the assay will be.  Finally, the recoveries had also been 
greatly improved.  The apparent recovery for a 20ng/g spike was 111%.   
 
In conclusion, it would seem that it was the starch present in the maize that was binding 
non-specifically to the surface of the chip.  The starch was successfully broken down by the 
amylase treatment, thus reducing the background and resulting in acceptable recoveries. 
 
 
 
                   
 
                       
 
Figure 4.4 Aflatoxin B1 extraction from maize with 55% (v/v) methanol/water, followed 
by a hexane step and then a final chloroform extraction after the maize had been treated 
with amylase. 
Maize was spiked with aflatoxin B1 to a concentration of 10 ng/g.  After an amylase 
treatment to remove starch, the sample was then extracted with 55% (v/v) 
methanol/water, followed by a hexane step and then a final chloroform extraction.  The 
recovery was found to be 111% and the coefficient of variation was 5.0% 
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4.5 Peanuts 
 
Peanuts are very susceptible to mould growth and, therefore, it is a commodity that is 
notorious for aflatoxin contamination.  The lowest regulatory limits that have been set for 
aflatoxin B1 in peanuts are by the EU and are 2ppb (2ng/g).   
 
 
The first extraction procedure attempted for the peanut assay using the “Easi-extract 
aflatoxin” immunoaffinity columns (IAC) was one recommended for peanuts in the 
protocol of the kit.  This involved an extraction step using 80% (v/v) methanol/water.  The 
peanuts used were reference material purchased from FAPAS (Food Analysis Performance 
Assessment Scheme).  They had been tested and certified as blank peanut samples.  
Controls to determine whether the use of filters was needed in the assay were also included.  
Half the blank sample and half the spiked sample were filtered using the PVDF 
(Polyvinylidene Fluoride) filters and the other half remained unfiltered.  This was to 
determine whether non-specific binding to the chip surface could be removed by the use of 
filters. 
 
A calibration curve was generated, but there is still some background present.  In buffer, the 
zero calibration gave a response of 648RU, whilst in extract the response was 1356RU.  
The filters did remove some non-specific binding as shown when comparing the samples 
that have been filtered to those that had not.  However, the recoveries were poor.  An 
average of 2.0ng/g was recovered, which was a 40% recovery.   A possible reason for this 
was that the high background was “masking” some of the recovery i.e. the background was 
so high that the specific binding cannot be differentiated from the non-specific.  Peanuts 
contain high amounts of fats, which are known to associate with the surface of the Biacore 
chip.  Fat binding to the surface produces a characteristic bend in the sensorgram, which 
was seen in this experiment.  Removal of fat from a sample can be achieved by 
incorporating a cyclohexane wash into the protocol, but when this was incorporated into the 
previous experiment the background actually increased. 
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Another extraction process described in the R-Biopharm Rhone protocol involved using 
60% (v/v) acetonitrile/water instead of 80% (v/v) methanol/water.  This extraction was 
carried out in the hope that less matrix effect would be extracted along with the aflatoxin.  
The background was significantly reduced using acetonitrile instead of methanol for the 
extraction solvent, the recoveries, however, were very poor.  The samples had been spiked 
with the equivalent of 5ng/g and the recovery was 1.21ng/g, which is 24.2%.  Interestingly, 
there did not seem to be too much difference between the filtered and unfiltered samples.  
This suggests that the filters were unnecessary and the experiment was repeated without 
filters.  Both spiked and real samples were used.  The real sample from FAPAS, which 
contained 2.06ng/g of aflatoxin B1 was also included in this experiment. 
 
The sample spiked with 5ng/g aflatoxin also showed good recovery (88%).  However, with 
the 2.5ng/g spike had very poor recovery.  The most worrying outcome of the experiment, 
however, was the responses from the real samples.  The real samples had responses of over 
2000RU.  When the samples were extracted they had also looked different, with the real 
samples producing a reddish liquid.  FAPAS were contacted to discover what was 
responsible for the differences between the blank and the positive samples were.  The blank 
samples had in fact been treated differently.  The blank sample had been blanched, the skin 
removed and milled with flour.  The positive samples had only been milled, without the 
addition of flour.  Since the blank sample was not 100% peanut it should not be used for the 
calibration curve.  Although there is no guarantee that commercially bought peanuts are 
aflatoxin-free, it was decided that a sample of these should be used for the calibration curve 
as they would be 100% peanut.  The peanuts chosen were bought from a health food shop 
called “Julian Graves”.  The reason for the high matrix effect was thought to be because the 
peanut skins contain tannins, which are known to bind to the sensor chip surface.  Other 
assays have used PVP to remove tannins to great effect 
 
The Julian Graves sample showed considerably more matrix effect than the FAPAS sample 
(1500-1600RU compared to approximately 800RU).  This shows that the matrix effect is 
indeed caused by the peanut skins.  The treatment of the peanuts with the PVP seemed to 
add to the matrix effect with both samples treated with PVP showing responses double that 
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than the untreated sample.  It was then decided to filter the samples and test then with 
manual injections.  Millex GS filters were selected as they had been used to remove PVP in 
previous assays.  This time all matrix effect were removed, including the sample that had 
not been treated with PVP.  It was concluded that the use of PVP was unnecessary, and that 
a simple filtration step would suffice.  However, Millex GS filters were known to sequester 
aflatoxin.  Therefore, a range of filters had to be evaluated. 
 
Six different filters were evaluated, to determine their effectiveness at removing matrix 
effects.  The possibility that filters might sequester aflatoxin was also investigated. To test 
if the matrix was removed, the peanut extract was filtered and the filtrate compared to HBS 
when run against a calibration curve.  Blank HBS and HBS that had been spiked at a 
concentration of 5ng/g were also treated using the different filters.  These too were 
compared to a calibration curve in HBS, and this enabled the calculation of recoveries.  
 
The results are shown in Table 4.4. They show that filters do remove the matrix 
interferences from the samples.  The response for the peanut extract without filtering was 
3346RU.  This shows a high level of non-specific binding to the surface when compared to 
the response of buffer alone (630RU).  The Millex GV filters remove approximately half 
the non-specific binding (NSB), but the aflatoxin recovery is only 14%.  The Millex GV 
and the Millex PVDF remove all the NSB, but the aflatoxin is completely removed from 
the sample by the filters.  The Ministart columns remove about half the NSB and the 
recovery was only 61%.  The Target filters removed all the NSB, but the recovery was only 
59%.  The best performing filters were both from Whatman.  The Whatman CA w/GMF 
filters eliminated all NSB and the recovery was 84%.  The best results, however, were 
using the Whatman Anotope filters which removed all NSB and had apparent recoveries of 
112%.  This test was performed only once.  It was thought that further tests were not 
necessary as the experiment was designed only to give a quick comparison between the 
filters.  The Whatman Anotope filters were found to be the most suitable for use in the 
aflatoxin/peanut assay. 
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Table 4.4 Table showing the efficacy of a range of different filters in removing matrix 
effect from peanuts whilst not sequestering aflatoxin B1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Filter Sample Type Response (RU) Recovery 
 
No filter 
Peanut extract 3346 N/A 
HBS 630 N/A 
HBS spiked with 10ng/g aflatoxin 123 160% 
 
Millex GV 
Peanut extract 1757 N/A 
HBS 578 N/A 
HBS spiked with 10ng/g aflatoxin 501 14% 
 
Millex GS 
Peanut extract 663 N/A 
HBS 683.7 N/A 
HBS spiked with 10ng/g aflatoxin 686 0% 
 
Millex PVDF 
Peanut extract 681 N/A 
HBS 686 N/A 
HBS spiked with 10ng/g aflatoxin 684 0% 
 
Ministart 
Peanut extract 1761 N/A 
HBS 663 N/A 
HBS spiked with 10ng/g aflatoxin 556.8 61% 
 
Target 
Peanut extract 739 N/A 
HBS 687 N/A 
HBS spiked with 10ng/g aflatoxin 277 59% 
 
Whatman 
Anatop 
Peanut extract 657 N/A 
HBS 676 N/A 
HBS spiked with 10ng/g aflatoxin 169 112% 
 
Whatman CA 
w/GMF 
Peanut extract 1082 N/A 
HBS 643 N/A 
HBS spiked with 10ng/g aflatoxin 215 84% 
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The assay with the acetonitrile extraction was then repeated using Whatman Anatop filters, 
as they had been proven to remove the matrix effect, whilst not removing aflatoxin B1. In 
this experiment, the Whatman filters removed all NSB, producing a good curve.  However, 
the recoveries for the 20ng/g spike are only 69% and the the aflatoxin was completely lost 
for the 10ng/g spike.  The protocol for peanuts described in the protocol for the Easi-extact 
columns had recommended a methanol extraction.  Therefore, the experiment was repeated 
replacing the 60% (v/v) acetonitrile/water with 80% (v/v) methanol/water. 
 
The recoveries, however, in this experiment were reading too high.  The 20ng/g spike was 
off the scale, the 10ng/g spike had an apparent recovery of 190%, while the 2ng/g spike had 
an apparent recovery of 400%.  The reasons for this are not known.  In order for the assay 
to be as comparable as possible, all samples and calibrants should be treated in exactly the 
same manner.  One difference between the samples and the calibrants is that all the sample 
is put through the filters, but the calibrants are only spiked after filtering.  The next 
experiment, therefore, was to spike the blank sample before filtering.  Two experiments 
were carried out.  The first had peanut samples spiked at 10ng/g, and second experiment 
had samples spiked at 10, 5 and 2ng/g. 
 
The first experiment, with a spiked sample of 10ng/g, had a recovery of 74%, which is an 
improvement on previous experiments.  The recoveries for the 10ng/g spike in the second 
experiment were again approximately 70% and the 5ng/g spike had a recovery of 106%.  
However the 2ng/g spike had the disappointing recovery of 31%.  This would suggest that 
the sensitivity of the curve is at 5ng/g.  This is not sensitive enough as this assay has to 
have a limit of detection less than 2ng/g because the regulatory limits are at this level.  The 
sensitivity of the assay had to be improved.  To improve the sensitivity of an assay the 
conditions of the experiment can be altered by changing the percentage antibody fraction 
and the injection time.  Previously the sensitivity of the assay had been optimized in an 
HBS buffer system, and the optimal conditions were an antibody fraction of 30% and an 
injection time of 8 minutes.  However, a calibration curve in buffer will often be different 
than that produced using sample extract.  A sample after extraction will frequently have 
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some components present that will contribute to some level of matrix effect.  Therefore, it 
is better to create a calibration curve using standards of the sample matrix, which would 
then account for any matrix effect there is in the sample.  In this case the matrix is peanut, 
and the standard samples were produced by following the same extraction procedure for 
that of the samples.  This is described in 2.3.5d. 
 
 
This experiment was therefore repeated using peanut extract.  The previous assay 
conditions had been an antibody fraction of 30% and an injection time of 8 minutes.  To 
improve the sensitivity other conditions were carried out (30% antibody fraction, 10 minute 
injection time; 30% antibody fraction, 8 minute injection time; 20% antibody fraction, 10 
minute injection time; 10% antibody fraction, 8 minute injection time; 10% antibody 
fraction, 10 minute injection time).  The results are shown in Figure 4.5. 
 
The optimization experiment showed that the most sensitive curve, still maintaining a good 
range, was an antibody fraction of 20% and an injection of 10 minutes.  The more sensitive 
a curve is, the lower the midpoint will be.  This is shown in figure 4.5., where there was the 
largest drop between 0.0 and 0.1ng/g for these conditions compared to the others showing 
the most sensitivity at this point in the calibration curve. 
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Figure 4.5 Optimisation of the aflatoxin B1 assay in peanuts. 
To improve the sensitivity of the assay, different antibody injection times and percentage 
fractions were compared using a calibration curve constructed using blank peanut 
sample. 
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An assay was set up using these new assay conditions with an antibody fraction of 20% and 
an injection of 10 minutes to determine if this did in fact improve the sensitivity.  The assay 
used 80% methanol as the extraction solvent, IAC for the clean-up and spiking the 
calibrants before filtering using the Whatman anotop filters.  Results are shown in figure 
4.6. 
 
 
 
 
Figure 4.6 Aflatoxin B1 extraction from peanuts using the new assay conditions of an 
antibody fraction of 20% and an injection of 10 minutes.  80% methanol was used as the 
extraction solvent, IAC for the clean-up and the calibrants were spiked before filtering 
using the Whatman Anotop filters.  Apart from the first sample where the recovery was 
only 42.7%, all other recoveries ranged from 85% to an apparent recovery of 103%. 
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These results indicated that the sensitivity of the assay may have improved and that the 
assay was potentially more accurate at the lower end of the calibration curve.  This is 
reflected in the recoveries.  Although the recovery for the first sample was low, all the other 
recoveries were over 85%.  The reason why the recovery for the first sample is so low is 
not known. 
 
 
Table 4.5  Table showing sample recoveries from the Aflatoxin B1 extraction from 
peanuts using the new assay conditions of an antibody fraction of 20% and an injection 
of 10 minutes.  80% methanol was used as the extraction solvent, IAC for the clean-up 
and the calibrants were spiked before filtering using the Whatman anotop filters.  Apart 
from the first sample where the recovery was only 42.7%, all other recoveries ranged 
from over 85%. 
 
Sample Concentration of 
aflatoxin B1 in 
sample (ng/g) 
Apparent recovery 
of sample (ng/g) 
Percentage recovery 
of sample 
1 2 0.854 43% 
2 2 1.95 98% 
3 2 2.06 103% 
4 5 4.54 91% 
5 4* 3.39 85% 
*Sample 5 (4ng/g) was two 2ng/g samples passed through the same column. 
 
European sampling laws for aflatoxin B1 states that the minimum sample size is 50g.  
Therefore, if this assay was to be developed into a diagnostic kit, the sample size must be 
increased from 1g to 50g.  To test whether the assay would still be effective using the larger 
sample size it as scaled up by 50 times, where 50g of peanuts were spiked at 10ng/g and 
extracted using 500ml of 80% methanol.  After incubation for 30 minutes and 
centrifugation at 2000g, 2ml of the solvent was removed and the assay was repeated (as 
described in 2.3.5d). 
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Figure 4.7  Aflatoxin B1 extraction from peanuts using an increased sample size of 50g.  
80% methanol was used as the extraction solvent, IAC for the clean-up and the 
calibrants were spiked before filtering using the Whatman anotop filters.   
 
 
The results of the experiment using the increased sample size of 50g were promising.  The 
apparent recoveries of the samples spiked with 2ng/g of aflatoxin B1 were 1.76 and 1.91ng, 
which are 88% and 96%, respectively (Figure 4.7).  However, the percentage coefficient t 
of variation between some of the points in the calibration curve were high (53.3 for the 
0.5ng spike).  Ideally these should be below 10.   The reason for this was because the 
trendplot of the baseline had risen over the course of the experiment (figure 4.8).   The 
baseline trendplot records the response after the regeneration solution has passed over the 
surface.   
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Figure 4.8  Baseline Trendplot. 
This shows that the baseline has steadily increased by apporoximately 400RU over the 
course of the experiment.  This is due to a build up of material on the sensor ship surface 
which will interfere with the efficacy of the assay. 
 
 
An explanation as to why the baseline is increasing is that there is a steady build up of 
material on the surface of the chip, which is not being removed by the regeneration 
solution.  This, in turn, was interfering with the assay.  One way to resolve this would be to 
optimise the regeneration solution.  Therefore, although the results seem promising, further 
optimisation of the assay was still required.   
 
 
 
 Chapter 5: 
Discussion  
and 
Conclusions 
 
 
5.1  Aflatoxin  B1 Detection and Quantification 
 
Aflatoxin B1 is a mycotoxin, a toxic secondary metabolite produced from the toxigenic 
filamentous fungi Aspergillus flavus and Aspergillus parasciticus.  Aflatoxin B1 is 
produced in hot and humid tropical conditions and is known to contaminate a wide range of 
crops, including nuts (peanuts, almonds, pistachio, walnuts and brazil nuts), cereals (maize, 
wheat, rice, oats, sorgam) and spices (chilli, black pepper, turmeric, ginger). 
 
Aflatoxin B1 is highly toxic and primarily targets the liver and has a positive association 
with human hepatocellular carcinoma.  Aflatoxin B1 contamination can occur at anytime 
throughout the farming process, including storage and transportation, which makes 
aflatoxin contamination a worldwide problem.  Therefore, approximately 100 countries 
have imposed regulatory limits for aflatoxin B1 in order to limit exposure.  The limits that 
have been set for aflatoxin B1 are low, primarily due its possible carcinogenic effects.   The 
lowest regulations that have been set are to protect the most susceptible to aflatoxin B1 
toxicity, and these are for infant formula, which was set by the EU in 2006 at 0.05ng/g. 
 
The imposture of strict regulatory limits for aflatoxin B1 has necessitated the development 
of reliable, sensitive analytical methods to detect and quantify aflatoxin B1.  Several official 
regulatory organisations, for example Association of Official Analytical Chemists (AOAC), 
the International Union of Pure and Applied Chemistry (IUPAC), International 
Organisation for Standardisation (ISO), and its European counterpart, the European 
Committee for Standardisation (CEN), have validated numerous methods.  Many of these 
methods use a chromatographic technique, such as gas chromatography (GC), high-
performance liquid chromatography (HPLC), liquid chromatography with mass 
spectrometry (LC-MS) or tandem mass spectrometry (LC-MS/MS).   Although these 
methods are sensitive enough to detect aflatoxin B1 to the regulatory limits, they are not 
without disadvantages.  All use large quantities of hazardous solvents and require skilled 
training to execute.  They are also time consuming and labour intensive, and are therefore 
not suitable for testing large numbers of samples.  They are also very expensive. 
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These disadvantages have necessitated the development of new diagnostic techniques for 
aflatoxin B1.  The assays must be reliable, simple to use and sensitive enough to detect to 
the lowest regulatory limits.  They have to be sufficiently robust to use on the many 
different types of food affected by aflatoxin B1, have a high-throughput capacity, be able to 
test many samples quickly and accurately, and they must also be cost effective. 
 
The purpose of this study was to develop a diagnostic kit for aflatoxin B1 using Surface 
Plasmon Resonance (SPR).  SPR is an innovative optical technique that measures 
biomolecular interactions on the surface of a sensor chip.  The biomolecular interactions are 
between the analyte of interest (in this case aflatoxin B1) and its binding partner.  In this 
assay the binding partner is an antibody.  The association and disassociation of aflatoxin B1 
with its antibody can be followed in “real-time” on a graph called a sensorgram.  Other 
advantages of SPR are that it is label-free, it is high-throughput, its associated software is 
windows-led and straightforward to use, it does not use large volumes of solvents and is 
both accurate and sensitive. 
 
5.2  Assay development and feasibility 
 
To determine the feasibility of an assay several aspects have to be considered.  The first 
was the format of the assay.   When the molecule to be tested is small (less than 312 Da), as 
is the case for aflatoxin B1, the assay has to be an inhibition assay as the change in 
resonance when the molecule binds to the surface would otherwise be negligible.   
 
The second parameter was the efficacy of the chip surface.  In an inhibition assay, the 
analyte or a derivative of the analyte is immobilised onto the chip surface.  The analyte or 
derivative may not be orientated correctly (i.e. with its epitope easily accessible) on the 
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surface, and therefore the surface should be tested by performing an Rmax (section 3.3).  
This is when antibody is passed across the surface in large excess.  If the immobilisation is 
successful, the response should be several thousand RU.  In the case of the aflatoxin B1 
assay, the most effective surface was with the aflatoxin B1-oxime-ethylenediamine 
derivative immobilised. 
 
Thirdly, the assay should work in a buffer system.  Although the Rmax may indicate that 
there is binding of the antibody to the surface, a standard curve has to be generated to 
enable analyte quantification.  A curve was produced for the aflatoxin B1 assay in an HBS-
EP buffer system using aflatoxin B1 standards (0, 0.5, 1.0, 2.5, 5.0 and 10ng/g of aflatoxin 
B1). 
 
Finally, the sensitivity of the antibody is extremely important.  Regulatory limits for 
aflatoxin B1 have been set as low as 0.05 ng/g.  These limits were set by the EU for infant 
formula.  For the assay to be feasible the antibody must be sensitive enough to detect 
aflatoxin B1 to these levels.  Several antibodies were evaluated for this assay.  The most 
sensitive was found to be the Fab antibody, G6. 
 
5.3 Aflatoxin B1 assay with compound feed (IRMM Reference Material) as 
the sample matrix  
 
The first matrix that was investigated was compound feed as it could be bought as a 
certified reference material from Sigma Aldridge.  Two samples were purchased, one that 
had been certified to contain no aflatoxin B1  (blank) and another containing 9.3ng/g 
aflatoxin B1. 
 
A simple methanol extraction was first attempted.  There was, however, too much 
interference from the sample matrix and a calibration curve using blank extracted sample 
could not be generated.   To remove the interference, a solid phase extraction column, 
“Mycosep” from Romer Laboratories was used in the sample clean-up.  Unfortunately, 
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there was still non-specific binding of the matrix onto the chip surface, and a calibration 
curve could not be produced. 
 
The immunoaffinity columns “Easi-extract Aflatoxin” from R-Biopharm Rhone were then 
evaluated.  Their use reduced the interference and a calibration curve was generated.  Also, 
the recoveries for the certified compound feed sample were excellent.  The compound feed 
had been certified to contain 9.3ng/g aflatoxin B1.  When read off the calibration curve the 
compound feed appeared to contain 9.35ng/g.  This was a recovery of 100.5%.  The 
experiment was repeated, and again the recoveries were excellent at 98%. 
 
The major disadvantage of using immunoaffinty columns, however, is that they were very 
expensive, especially since it was proven that they could not be re-used.  Cheaper 
“Aflatest”  IAC columns, were therefore sourced from Vicam.  However, their performance 
was disappointing.  Although the matrix effect was again removed, the recoveries were 
poor at only 50%. 
 
Overall, the preliminary assays using compound feed were promising.  The feasibility of 
the assay, extracting Aflatoxin B1 from a real sample, had been demonstrated.  However, 
there were problems with interferences from the matrix resulting in non-specific binding to 
the Biacore chip surface.   The most effective way of resolving this problem was to use 
immunoaffinity columns.  The use of these columns, however, would result in assay costs 
that were potentially prohibitive. 
 
5.4 Aflatoxin B1 assay with infant formula as the sample matrix 
 
The next matrix chosen for investigation was infant formula.  The lowest regulatory limits 
for aflatoxin B1 in any food have been set for infant formula by the EU at 0.05ng/g.  There 
are no rapid methods on the market at present that are sufficiently sensitive to detect 
aflatoxin B1 to these levels.  This would be a unique selling point for the kit, and for this 
reason infant formula was chosen as the matrix to investigate. 
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Simple extraction procedures were first examined.  Unfortunately, as previously found with 
compound feed, there were problems with matrix interference.  Infant formula has a high 
fat content, and it was perceived that it may be the fat that is binding to the surface of the 
chip.  A cyclohexane step was introduced to remove the fat from the sample.  The non-
specific binding to the chip surface was removed and a calibration curve generated, but the 
recoveries, however, were poor at approximately 10%.  In addition, the aflatoxin B1 seemed 
to be removed from the sample along with the fat. 
 
Further attempts to reduce matrix interference were carried out by precipitating out 
proteins.  These too resulted in low recoveries. 
 
Promising results had been achieved for compound feed using “Easi-extract aflatoxin” 
immunoafinity columns.  Therefore, these columns were utilised in the clean-up of the 
assay for infant formula.  Recoveries were satisfactory for samples spiked with aflatoxin B1 
at 5ng/g (the average recovery was 78%).  The recoveries of samples spiked at 1ng/g, 
however, were erratic.  This was because the sensitivity at this point of the curve was poor.  
Unfortunately, with regulatory limits of 0.05ng/g for infant formula, the sensitivity of the 
curve at this point must be better in order to detect and quantify accurately.  However, 
despite very significant efforts, it was not possible to achieve a calibration curve sensitive 
enough to test for aflatoxin B1 in infant formula to the regulatory limits.  The assay, 
therefore, was obsolete, and it was decided to focus on a different matrix (or matrices) that 
had regulatory limits for aflatoxin B1 within the performance characteristics of the assay.   
 
5.5  Aflatoxin B1 assay with maize as the sample matrix 
 
The infant formula and compound feed assays both had problems with matrix interference 
binding to the surface of the chip.  Unlike infant formula, maize does not have a high fat 
content which was the possible cause of non-specific binding to the chip surface.  
Compound feed is composed of up to 30 different ingredients, including vitamins, minerals, 
fermentation products e.g. ash and antibiotics, which all could cause matrix effects.  Maize 
was chosen to investigate primarily because it was thought that it, out of all other matrices, 
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it might have the least problems with matrix effects.  The reduction in matrix effects would 
therefore negate the need for immunaffinity columns. 
 
With maize the AOAC recommends a 55% (v/v) methanol/water extraction followed by a 
hexane step and then a chloroform extraction.  Again, however, matrix interferences gave 
rise to a background that was too high.  This matrix effect was still evident even after an 
additional clean-up step using  “Easi-extract aflatoxin” immunoaffinity columns.  Maize is 
composed of 62% starch, which could be the root cause of the matrix effect.  Therefore, an 
amylase treatment step was introduced to the method in an attempt to remove non-specific 
binding.  After amylase treatment, there was an 80% (v/v) methanol/water extraction 
followed by clean-up using the “Easi-extract aflatoxin” immunoaffinity columns.  This 
additional step did reduce the background from 1760RU to 1280RU, but this is still 
approximately double the background with buffer alone.  In spite of this, a calibration curve 
was still generated and the recovery for a 20ng/g aflatoxin B1 spiked sample was 111%. 
 
The purpose of the immunoaffinity column was to remove all matrix from a sample 
producing a pure and concentrated solution of aflatoxin B1.  Unfortunately we found that in 
the case of maize that some interference was still remaining in the sample that bound non-
specifically to the sensor chip surface.   The assay was therefore problematic. There was 
pressure to produce a marketable assay as quickly as possible and so a new matrix, peanuts, 
was chosen to investigate.  
 
5.6  Aflatoxin B1 assay with peanuts as the sample matrix 
 
The final matrix examined in this study was peanuts.  “Easi-extract aflatoxin” 
immunoaffinity columns were used for sample clean-up to remove matrix interferences.  
Two extraction methods were recommended by the immunoaffinity column kit, 80% (v/v) 
methanol/water and 60% (v/v) acetonitrile/water.  The methanol extraction still resulted in 
a high degree of matrix non-specific binding.  Although the background with the 
acetonitrile extraction was reduced, the recoveries were poor at approximately 24%.  There 
was also a difference between the backgrounds of samples that had been filtered compared 
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to the backgrounds of unfiltered samples.  An evaluation of six different filters was carried 
out, first on their effectiveness on removing matrix effect and secondly on whether or not 
any aflatoxin B1 was removed from the sample and sequestered by the filter.  There were 
huge differences between the filters.  Some removed all matrix interferences , whilst others 
only removed half (see table 4.5.1).  Some of the filters also removed all of the aflatoxin 
B1.  The best performing filters were the Whatman Anotop filters, which removed all of the 
non-specific binding but none of the aflatoxin B1. 
 
The peanut assay was repeated using these filters.  A methanol extraction was performed 
before clean-up using immunoaffinity columns.  Also, the calibrants were spiked before 
extraction.  Three different spiked samples were assessed.  They were spiked at 10, 5 and 
2ng/g.  The recoveries were 70%, 106% and 31%, respectively.  This would suggest that 
the sensitivity of the calibration curve is at 5ng/g as the readings were most accurate around 
this point.  The regulatory limits set for aflatoxin B1 in peanuts is 2ng/g.  Therefore the 
assay was not sensitive enough.   
 
The assay conditions were optimised to improve the sensitivity of the calibration curve.  
The assay conditions were altered slightly, which greatly improved the recoveries of the 
samples spiked at 2ng/g.  Although the first sample had a recovery of only 43%, the other 
two samples spiked at 2ng/g had recoveries of 98% and 103%.  For all three samples, this 
had an average recovery of 81%. 
 
Sampling laws for aflatoxin B1 state that the minimum sample size is 50g.  Keeping all 
conditions the same, the assays were scaled up from 1g to 50g of peanuts.  In this assay two 
50g samples were spiked at 2ng/g.  The recoveries were excellent at 88% and 96%. 
 
5.7  Comparison of assay with current market leaders 
 
The global market share for mycotoxin testing is estimated at approximately £75 –100 
million, with rapid diagnostic methods accounting for 10 – 20% of this (Council for 
Agricultural Science and Technology (CAST) report, 2003).  This is a fairly new market 
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and, therefore, the average annual growth is high at 10%.  Aflatoxins, and aflatoxin B1 in 
particular, are the best known and studied mycotoxins and are proven to be the most 
carcinogenic.  Therefore, most mycotoxin diagnostic kits on the market are for aflatoxin B1 
or total aflatoxins.  They also have the most complete regulatory limits compared to other 
mycotoxins.   
 
There are, however, already a number of competitors on the market, but due to changing 
legislation demanding increased testing and the ability to detect lower levels, this sector is 
growing fast.  There is, therefore, a niche in the market for high-throughput, automated 
systems that is sensitive enough to meet the demands of the lowering regulatory limits.   
 
Aflatoxin B1 testing generally falls into two groups.  The first is analytical chromatographic 
methods.  These methods, such HPLC, TLC, HPLC/MS and GC/MS are reliable, sensitive 
and quantitative.  These conventional analytic methods, however, are time consuming, 
labour intensive and require skilled training.  They also require high consumption of 
hazardous solvents, and, so, are often expensive.  These tests would be too expensive and 
time consuming to analysis large numbers of samples, but can be used as confirmatory 
tests. 
 
Table 5.1 Table showing analytical laboratory techniques for aflatoxin analysis and their 
relative advantages and disadvantages 
Method Advantages Disadvantages 
TLC - Simple 
- Cheap 
- Rapid 
Separation may be 
unsatisfactory 
Poor precision 
Needs confirmation 
HPLC - Sensitive 
- Selective 
- Easy to automate 
- Compounds may require 
derivatisation 
- Method requires skilled end-
user 
- Expensive  
HPLC/MS - Provides high level of confirmation 
- Multi-analyte detection 
- Very sensitive 
- Expensive 
- Specialist expertise required. 
GC/MS - Very sensitive - Expensive 
- Specialised expertise 
required 
- Compounds must be volatile. 
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The second type of aflatoxin B1 tests are antibody-based.  These diagnostic tests, such as 
ELISAs and lateral flow tests (“dipstick” tests), are now taking over the mycotoxin testing 
market.  They are commercially available in a kit form and are a simpler, quicker and 
cheaper means to routinely monitor aflatoxin contamination.  The main disadvantage of 
immunological kits is that they are not quantitative and therefore the results may still 
require confirmation by an analytical method, such as HPLC.   Other disadvantages are 
false positives or false negatives and they may have matrix interference problems. 
 
There are currently a number of these kits on the market.  The main market leaders are r-
Biopharm, Romer, Diffchamp, Neogen and Charm, who between them share 60 –70% of 
the market share. 
 
Romer (www.romerlabs.com) 
Romer Labs is a world leader in the development of mycotoxin test kits.  It has a wide and 
comprehensive portfolio of different tests for aflatoxins, each designed for specific 
analyses, depending on the number of samples to be analysed, the matrix or whether or not 
it is to be quantitative of qualitative.  All assays are both AOAC and USDA/GIPSA 
approved.  They currently have four kits on the market that test for aflatoxins. 
 
i) AgraQuant ELISA kits for total aflatoxin 
 
This kit tests for total aflatoxins in grain, nuts, cottonseeds, cereals and other commodities 
such as animal feeds.  It has two quantitation ranges, 1-20ppb and 4-40ppb (with limits of 
detection 1 and 3ppb, respectively). 
ii)  FluoroQuant Total Aflatoxin test kit 
FluoroQuant is a rapid, quantitative fluorometric test kit for total aflatoxin specially 
formulated for the needs of the grain industry.  It has a limit of detection of 1ppb and can be 
used to test corn, wheat, soybeans, raw peanuts, rice and cottonseed. 
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iii)  AflaCup Kit for total aflatoxins 
AflaCup is a test designed for single sample testing.  It has detection level of 10ppb, but is a 
qualitative test, giving only yes/no answers. 
 
iv) AgriStrip lateral flow kit 
This a one step lateral flow immunochromatographic assay to determine the presence of 
aflatoxins B1, B2, G1 and G2.  The strips are designed for in-situ testing at grain elevators 
and peanut buying points.    The strips have cut off levels at 4, 10 and 20 ppb.  Again, this 
is a qualitative test, giving only yes/no answers.  The test involves comparison by eye, so 
results would be somewhat open to interpretation. 
 
Charm (www.charm.com) 
 
Charm Sciences have recently achieved approval from the USDA/GIPSA for their aflatoxin 
test.  No other test has ever received approval for such a comprehensive list of 
commodities.  These are corn, corn flour, corn germ meal, corn gluten meal, corn meal, 
corn screenings, corn soy blend, cracked corn, distillers dried grains, flaking corn grits, 
milled rice, popcorn, rough rice, sorghum, soybeans and wheat.  The procedure includes a 
sample extraction and a ten minute incubation with a test strip.  The strip is then inserted 
into a reader, which then displays and records the reading.  The limit of detection is 2ppb, 
and the range is 0-100ppb. 
 
R-Biopharm Rhone (www.r-biopharm.com) 
 
In addition to marketing several IAC for aflatoxin sample clean-up, R-Biopharm Rhone 
also produce kits for aflatoxin detection and/or quantification.  They currently have two 
ELISAs on the market to test for aflatoxins. 
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i) AflaPlate 
 
This is a quantitative ELISA for the analysis of aflatoxin B1.  It has a limits of detection of 
1ppb and the test matrices include maize, nuts and animal feed. 
 
ii) Aflacard B1 and Aflacard total 
 
These are qualititative screening cards for the detection of either aflatoxin B1 or total 
aflatoxins, working in the same was as a lateral flow immunoassay.  They have a detection 
limit of 2ppb and gives a yes/no answer by way of a colour change, and, so, the results are 
open to interpretation. 
 
Diffchamp 
 
Diffchamp also has an ELISA on the market that tests for and quatifies aflatoxin B1.  It tests 
matrices such as cerals, peanuts, maize, wheat, nuts, figs, spices, tea, cocoa and animal 
feeds.  It has the lowest detection limit on the market of 0.5ppb and the test can also be 
automated using the transia Elisamatic II. 
 
The number of competitors is high, but there is still a niche in the market that necessitates 
the development of this assay using the Biacore SPR system.  The main selling point 
Xenosense has for this kit is product innovation, and it will be the only kit on the market 
that is fully automated.  This will allow analysis of large numbers of samples and in a short 
time. The hope is that the final assay will be more reliable and robust than other 
quantitative techniques, with little inter or intra laboratory variation in results due to the 
reduction in operator handling of samples.   
 
Aflatoxin assays have been developed on other analysers, harnessing different technologies, 
for example optical waveguide lightmode spectropscopy (Adanyi et al., 2007), sol particle 
immunoassay (Brenn-Struckhofova et al., 2007), fluorescence polarisation (Nasir et al., 
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2002), affinity electrochemistry (Mascini et al., 2001), fluid based-bioaerosols and surface 
plasmon resonance (SPR) (Daly et al., 2000; Maragos et al., 2002; Dunne et al., 2005).   
However, only Biacore has the capability of producing and manufacturing commercial kits 
for the assay.  Thirteen kits are presently on the market that test for either vitamins or drug 
residues using the Biacore system.  Xenosense, with its current repertoire of kits, therefore, 
has a strong customer base, and some of these customers have also expressed an interest in 
the Aflatoxin B1 kit.  Customers include industrial end users in the food industry, such as 
Nestle, Fonterra and Wyeth Nutrition; and regulatory end users, e.g. Livmedelsverket 
(Sweden), Department of Livestock Development (Thailand), Central Sciences 
Laboratories (UK) and Teagasc (Ireland).  These customers will have already bought the 
biosensors to use with either vitamin or drug residue kits.   
 
 
5.8  Conclusions 
 
The purpose of this study was to develop such an assay that combines the use of innovative 
technologies of surface plasmon resonance and recombinant antibody manipulation.  The 
hope was to develop a user friendly assay that could be marketed as a kit for use on the 
BiacoreTM Q biosensor. 
 
Four different types of food matrix where investigated – compound feed (IRMM certified 
material), infant formula, maize and peanuts.  The first material investigated, compound 
feed, proved that the assay was feasible in this matrix.  The certified reference material 
used in the assay had recoveries of over 98%. 
 
The infant formula assay was disappointing.  The regulatory limits for infant formula are 
the lowest limits that have been set for aflatoxin B1 and were set by the EU at 0.05ng/g.  At 
present there are no rapid tests on the market that can detect aflatoxin B1 to these levels.  
This would be the unique selling point of this kit.  Unfortunately, the assay was not 
sensitive enough to detect and quantify aflatoxin B1 to 0.05ng/g.    
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The third matrix examined was maize.  This assay proved problematic due to matrix 
interference.  There was non-specific binding of the maize matrix to the chip surface 
despite the use of immunoaffinity columns. 
 
The most promising matrix investigated was peanuts.  Recoveries of over 80% were 
achieved even when the whole process was scaled up to test aflatoxin B1 in sample sizes of 
50g.  However, further optimisation of the aflatoxin B1 assay in peanuts was still required.  
The trendplot for the baseline showed there was a steady increase as the assay progressed.  
This is indicative of build-up on the chip surface showing that the regeneration stage is not 
stringent enough.  Addition research into different regeneration solutions and regeneration 
injection times is required before going to the validation stage. 
 
The assay has two major disadvantages.  The disadvantages are the labourious extraction 
process and the reliance on immunoaffinity columns.  Simple extraction procedures were 
attempted, but all four foodstuffs in this study had problems with matrix effect causing non-
specific binding to the chip surface.  This resulted in backgrounds so high that either the 
required calibration curves could not be generated or the true recoveries were masked.  
Immunoaffinity columns are extremely expensive and cannot be re-used.  Although the use 
of the columns could be recommended along with the kit they would cause the price per 
analysis to become too high and I found that despite the use of the columns the extraction 
procedure was still very time consuming.  This would defeat two of the fundamental goals 
of the kit, i.e. that it should be more cost effective and it should be high-throughput.   The 
only solution to this problem may be to improve the chip surface.  This, however, would 
require the investigation to start again at the feasibility stage.  Unfortunately, this was 
beyond the scope of this project.  The reason for this was that, unfortunately, due to the 
economic downturn, Xenosense Ltd. ceased operating.  Xenosense had been bought over 
by Biacore, which, in turn had been purchased by GE Healthcare.  Global loses by GE 
Healthcare necessitated closures of many departments, including Xenosense. 
 
Overall, however, this study has shown that an aflatoxin B1 assay is possible using a 
Biacore Q biosensor.  Two matrices have shown great promise – peanuts and compound 
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feed.  Although some areas of the assay need further optimisation, namely the improvement 
of the chip surface and the development of a simpler extraction process, the investigation so 
far has proved feasibility.  Following optimisation, the next stages of the research would be 
validation of the assay.
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